var title_f3_1_3088="Convex probe";
var content_f3_1_3088=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F50764&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F50764&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Endobronchial ultrasound (EBUS) convex probe",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 355px; height: 385px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Linear curved array ultrasonic transducer on the end of an ultrasonic puncture bronchoscope. Used to perform convex probe endobronchial ultrasound. B) The balloon sheath that surrounds the ultrasonic transducer is inflated with water. A 22-gauge needle used for real-time transbronchial fine needle aspiration extends from the bronchoscope.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_1_3088=[""].join("\n");
var outline_f3_1_3088=null;
var title_f3_1_3089="Proximal subungual onychomycosis";
var content_f3_1_3089=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F81063&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F81063&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Proximal subungual onychomycosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Proximal, white discoloration of the nail plate is noted. The nail fold is uninvolved.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_1_3089=[""].join("\n");
var outline_f3_1_3089=null;
var title_f3_1_3090="Chapter 6L: Summary of hormone actions on the kidney";
var content_f3_1_3090=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"12\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Chapter 6L: Summary of hormone actions on the kidney",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/1/3090/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/1/3090/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/1/3090/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/1/3090/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/1/3090/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/1/3090/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/1/3090/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/1/3090/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 14, 2000.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Variations in hormone secretion are referred to as primary, ie, nonphysiologic, or secondary, i.e., physiologic. As an example, aldosterone release is appropriately increased by volume depletion; this is called secondary hyperaldosteronism. Conversely, the autonomous hypersecretion of aldosterone due to an adrenal adenoma, is referred to as primary hyperaldosteronism. A brief review of the clinical characteristics of these primary disorders can be helpful at this time by illustrating the role of the particular hormone in the regulation of water and electrolyte homeostasis. Most of these conditions will be discussed elsewhere in UpToDate.",
"   </p>",
"   <p>",
"    Primary excessive secretion of ADH results in increased water reabsorption in the collecting tubules. This is called the syndrome of inappropriate ADH secretion and is characterized by water retention, hypoosmolality, and hyponatremia. Volume expansion and edema do not occur in this disorder because, similar to the findings in aldosterone escape, the initial fluid retention leads to a spontaneous diuresis that may be mediated in part by a rise in renal perfusion pressure and perhaps by increased release of atrial natriuretic peptide (",
"    <a class=\"graphic graphic_figure graphicRef62044 \" href=\"UTD.htm?28/29/29150\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In contrast, water reabsorption is reduced in the absence of ADH, as large volumes (up to 10 to 20",
"    <span class=\"nowrap\">",
"     L/day)",
"    </span>",
"    of dilute urine are produced. This may be due to deficient hormone secretion (central diabetes insipidus) or to renal resistance to the effects of ADH (nephrogenic diabetes insipidus). Despite the polyuria, patients with either form of diabetes insipidus tend to remain in near normal water balance, because stimulation of thirst leads to an increase in fluid intake to match the high urine output.",
"   </p>",
"   <p>",
"    Primary hyperaldosteronism is associated with enhanced K+ and H+ secretion in the cortical collecting tubule, resulting in hypokalemia and metabolic alkalosis. The initial Na+ and water retention also promote the development of hypertension; however, fluid retention lasts for only a few days due to aldosterone escape.",
"   </p>",
"   <p>",
"    Hypoaldosteronism, in comparison, is characterized by variable degrees of hyperkalemia, metabolic acidosis, and Na+ wasting. The most prominent change is the rise in the plasma K+ concentration, since aldosterone is the primary hormone affecting urinary K+ excretion. Marked loss of Na+, on the other hand, is usually not a major feature of this disorder in adults, because other antinatriuretic factors (such as angiotensin II and a reduction in renal perfusion pressure) are activated by the initial volume depletion (see Chap. 8).",
"   </p>",
"   <p>",
"    PTH increases bone resorption, the urinary excretion of phosphate, and renal calcitriol synthesis. As a result, hypercalcemia and a normal or diminished plasma phosphate concentration are produced by the primary hypersecretion of PTH. In contrast, hypoparathyroidism leads to hypocalcemia (which is in part due to the associated calcitriol deficiency) and hyperphosphatemia.",
"   </p>",
"   <p>",
"    Calcitriol increases the availability of calcium and phosphate primarily by increasing their rate of intestinal absorption and their release from bone. Consequently, calcitriol deficiency is characterized by hypocalcemia and hypophosphatemia; lack of calcitriol may also be associated with rickets in children and osteomalacia in adults, since adequate levels of calcitriol, calcium, and phosphate are necessary for normal bone mineralization.",
"   </p>",
"   <p>",
"    Vitamin D excess (due to the chronic intake of high doses of vitamin D or to a granulomatous disease such as sarcoidosis) typically leads to increased intestinal Ca2+ absorption, enhanced bone resorption, hypercalciuria, and, in some cases, hypercalcemia [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3090/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. The changes in Ca2+ balance induced by prolonged ingestion of vitamin D are primarily due to calcifediol, the 25-hydroxylated precursor of calcitriol. The hepatic synthesis of calcifediol is substrate-dependent and not physiologically regulated [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3090/abstract/5\">",
"     5",
"    </a>",
"    ]; as a result, increased vitamin D intake can lead to a marked increase in calcifediol production [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3090/abstract/1\">",
"     1",
"    </a>",
"    ]. This compound is less active but, in this setting, is able to promote the development of hypercalcemia. In comparison, there is no large increase in calcitriol synthesis, because of the inhibitory effects of the rise in the plasma Ca2+ concentration and the associated reduction in PTH release [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3090/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This text is continued elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/23/12662?source=see_link\">",
"     \"Chapter 7A: Exchange of water between the cells and ECF\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    (From Rose, BD, Post, TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York, 2001.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3090/abstract/1\">",
"      Hughes MR, Baylink DJ, Jones PG, Haussler MR. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3. J Clin Invest 1976; 58:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3090/abstract/2\">",
"      Sharma OP. Vitamin D, calcium, and sarcoidosis. Chest 1996; 109:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3090/abstract/3\">",
"      Sandler LM, Winearls CG, Fraher LJ, et al. Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3. Q J Med 1984; 53:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3090/abstract/4\">",
"      Adams JS. Vitamin D metabolite-mediated hypercalcemia. Endocrinol Metab Clin North Am 1989; 18:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3090/abstract/5\">",
"      Holick MF. Vitamin D and the kidney. Kidney Int 1987; 32:912.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7252 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-11633CD92E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_1_3090=[""].join("\n");
var outline_f3_1_3090=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7252\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7252|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/29/29150\" title=\"figure 1\">",
"      Resumption of the steady state in primary aldosteronism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/23/12662?source=related_link\">",
"      Chapter 7A: Exchange of water between the cells and ECF",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_1_3091="E point septal separation LVEF";
var content_f3_1_3091=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F66756&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F66756&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    M-mode echocardiogram for estimating left ventricular function",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 263px; height: 316px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    M-mode echocardiogram can be used as a confirmatory adjunct to two dimensional evaluation of the left ventricle; the E point (of the mitral valve) septal separation (EPSS) is probably the most useful parameter. The M-mode echocardiogram was obtained prior to a myocardial infarction. The EPSS is 0 and the ejection fraction (EF) is normal. The panel on the right was obtained after the infarction; the EPSS is 13 mm and the EF is 40 percent. If EPSS is greater than 7 mm, there is a high likelihood that the EF is &lt;45 percent.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Dia: diastole; Sys: systole; MV: mitral valve.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_1_3091=[""].join("\n");
var outline_f3_1_3091=null;
var title_f3_1_3092="Ketotifen (ophthalmic): Patient drug information";
var content_f3_1_3092=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Ketotifen (ophthalmic): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/26/44453?source=see_link\">",
"     see \"Ketotifen (ophthalmic): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/53/25428?source=see_link\">",
"     see \"Ketotifen (ophthalmic): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F186116\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Alaway&trade; [OTC];",
"     </li>",
"     <li>",
"      Claritin&trade; Eye [OTC];",
"     </li>",
"     <li>",
"      Zaditor&reg; [OTC];",
"     </li>",
"     <li>",
"      ZyrTEC&reg; Itchy Eye [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F186117\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Zaditor&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10016817\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691836",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat eye swelling.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10016816\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702349",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to ketotifen or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10016821\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696947",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use this drug to treat contact lens irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10016822\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697930",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Burning.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698045",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Eye irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nose stuffiness.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10016824\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10016819\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For the eye only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695781",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take out contact lenses before using this drug. Lenses may be put back in 10 minutes after this drug is given. Do not put contacts back in if your eyes are irritated or infected.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not touch the container tip to the eye, lid, or other skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696124",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tilt your head back and drop drug into the eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694401",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       After use, keep your eyes closed. Put pressure on the inside corner of the eye. Do this for 1 to 2 minutes. This keeps the drug in your eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Space each eye drug by 5 minutes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10016820\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10016825\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10016826\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10784 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-93.125.6.160-7DBF348CA4-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_1_3092=[""].join("\n");
var outline_f3_1_3092=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186116\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F186117\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016817\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016816\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016821\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016822\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016824\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016819\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016820\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016825\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10016826\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?43/26/44453?source=related_link\">",
"      Ketotifen (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/53/25428?source=related_link\">",
"      Ketotifen (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?38/29/39379?source=related_link\">",
"      Ketotifen (systemic): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_1_3093="Casting tape short arm";
var content_f3_1_3093=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F81845&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F81845&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Casting tape for a short arm cast",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 355px; height: 468px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Casting tape is applied over the cast padding in a distal to caudal direction. When applying fiberglass tape, stretch and then relax the tape during application to reduce the skin surface pressure.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Stephen Titus, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_1_3093=[""].join("\n");
var outline_f3_1_3093=null;
var title_f3_1_3094="Inflicted subdural hematomas";
var content_f3_1_3094=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F78781&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F78781&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 530px\">",
"   <div class=\"ttl\">",
"    Inflicted subdural hematomas",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 510px; height: 509px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A three month old child presented with altered mental status and bulging fontanelle. There was no significant antecedent history given by the caretakers. Computed tomography images (Figures A and B) reveal hemorrhage within the subdural space extending both around the hemisphere and interhemispherically. There is also the question of ischemic changes. Diffusion weighted magnetic resonance imaging (Figure C) performed a few hours later confirm significant ischemic changes. The gradient echo magnetic resonance image (Figure D), sensitive to blood, further defines the hemorrhage in the subdural space. The child was found to have severe bilateral retinal hemorrhages and non-accidental trauma was suspected.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_1_3094=[""].join("\n");
var outline_f3_1_3094=null;
var title_f3_1_3095="Examination for gynecomastia";
var content_f3_1_3095=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F58568&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F58568&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Examination for gynecomastia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 369px; height: 345px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Physical examination method to distinguish gynecomastia, due to enlargement of the glandular tissue, from pseudogynecomastia, due to excessive adipose tissue. The thumb and forefinger are placed on opposite sides of the breast and slowly brought together towards the areolar-nipple complex. Gynecomastia is appreciated as a concentric, rubbery-to-firm disk of tissue, often mobile, located directly beneath the areolar area. Pseudogynecomastia presents no discrete mass, and other masses due to disorders such as cancer tend to be eccentrically positioned (insert).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Braunstein, GD, Hosp Pract 1993; 28:37.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_1_3095=[""].join("\n");
var outline_f3_1_3095=null;
var title_f3_1_3096="Echocardiographic evaluation of ventricular septal defects";
var content_f3_1_3096=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Echocardiographic evaluation of ventricular septal defects",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/1/3096/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/1/3096/contributors\">",
"     Ann Kavanaugh-McHugh, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/1/3096/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/1/3096/contributors\">",
"     Warren J Manning, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/1/3096/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/1/3096/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/1/3096/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 22, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A ventricular septal defect (VSD) is one of the most common congenital cardiac abnormalities in the newborn, but it is less common in the adult due to spontaneous closure of most muscular VSDs during early growth. It can occur as an isolated finding or in combination with other congenital defects. VSD can also be an acquired disorder, occurring after acute myocardial infarction or chest wall trauma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/19/39225?source=see_link\">",
"     \"Mechanical complications of acute myocardial infarction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The echocardiographic evaluation of VSD will be reviewed here. Alternative imaging modalities for assessing VSDs, as well as the pathophysiology and clinical features of this defect, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/3/34874?source=see_link&amp;anchor=H34#H34\">",
"     \"Clinical utility of cardiovascular magnetic resonance imaging\", section on 'Congenital heart disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/19/8506?source=see_link\">",
"     \"Pathophysiology and clinical features of isolated ventricular septal defects in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ECHOCARDIOGRAPHIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Echocardiography is valuable not only in diagnosing VSDs but also in the percutaneous and surgical treatment of these defects. Echocardiographic evaluation of VSDs includes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Identification of the location of defects on the septum",
"     </li>",
"     <li>",
"      Establishing the number of defects",
"     </li>",
"     <li>",
"      Delineation of associated anatomic features",
"     </li>",
"     <li>",
"      Assessment of the size and hemodynamic significance of the defects",
"     </li>",
"     <li>",
"      Guidance of interventional and surgical treatment",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The septum is a complex curved surface; traditionally careful assessment using multiple two-dimensional (2D) echocardiographic planes has been used to define the location and extension of defects. Although defects are generally described as membranous, muscular, supracristal, and inlet, a single VSD may not be confined to any one region of the septum but may extend into multiple adjacent regions (",
"    <a class=\"graphic graphic_figure graphicRef55308 \" href=\"UTD.htm?23/10/23720\">",
"     figure 1",
"    </a>",
"    ). Additionally, multiple defects in one or more regions of the septum may also be present. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/19/8506?source=see_link\">",
"     \"Pathophysiology and clinical features of isolated ventricular septal defects in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Color flow Doppler is a very useful adjunctive method to search and screen for VSDs. This modality can be used to help localize and confirm the presence of VSDs by their characteristic flow patterns.",
"   </p>",
"   <p>",
"    Three-dimensional (3D) echocardiography can also be used to define the anatomy of VSDs [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3096/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. 3D echocardiography allows localization of the defect and defining its relationship to other cardiac structures, and is superior to 2D imaging in delineating the shape and size of the VSD(s). This information is particularly important in choosing candidates and selecting devices for catheter based closure of defects, and in the management of muscular ventricular septal defects in particular [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3096/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23146?source=see_link\">",
"     \"Three-dimensional echocardiography\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Given the increasing availability of real-time 3D echocardiography and the expanding field of interventional and hybrid procedures for treatment of VSDs, echocardiography has an essential role in both the catheterization and surgical suites. Like 2D imaging, 3D echocardiography can be performed either from a transthoracic or transesophageal approach. In the catheterization laboratory, transesophageal echocardiography (TEE) is used to guide the positioning of sheaths, wires, and devices, and for confirmation of appropriate position and adequacy of closure post device deployment. In the operating room, positioning may be guided by TEE or direct visualization and is used for the assessment of device position and defect closure post deployment (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61269 \" href=\"UTD.htm?41/4/42052\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef72636 \" href=\"UTD.htm?38/50/39716\">",
"     movie 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef81090 \" href=\"UTD.htm?35/34/36388\">",
"     movie 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3096/abstract/5-7\">",
"     5-7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Respiratory artifact may limit image transthoracic acquisition in some patients, and some offline analysis may be required even with real-time 3D imaging. Sedation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    anesthesia may be required for optimal results in young children. TEE decreases the likelihood of difficulties with suboptimal acoustic windows and presents fewer logistic challenges in the course of operative and catheter-based procedures. Current TEE probes with 3D imaging capabilities are recommended for use in adults and in children over 30 kg, thereby excluding their use in a significant portion of the pediatric population.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Membranous VSD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Defects in the membranous septum are located at the intersection of the trabecular, inlet, and outlet regions of the septum, situated just apical to the aortic valve and beneath the septal leaflet of the tricuspid valve. In the parasternal long axis echocardiographic view, these defects are seen just below the aortic valve (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50069 \" href=\"UTD.htm?14/36/14918\">",
"     image 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef71163 \" href=\"UTD.htm?12/58/13222\">",
"     movie 3",
"    </a>",
"    ). In the orthogonal short axis views of the left ventricular outflow tract, perimembranous defects can be seen beneath the septal leaflet of the tricuspid valve (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef67557 \" href=\"UTD.htm?28/56/29574\">",
"     image 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef55781 \" href=\"UTD.htm?27/13/27862\">",
"     movie 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Membranous defects can also be seen beneath the aortic valve in apical imaging planes by angling the transthoracic transducer anteriorly toward the aortic outflow tract. In smaller patients with good subcostal imaging windows, the boundaries of these defects are imaged well in the coronal (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef70762 \" href=\"UTD.htm?20/55/21362\">",
"     image 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef58967 \" href=\"UTD.htm?19/19/19762\">",
"     movie 5",
"    </a>",
"    ) and sagittal (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef71248 \" href=\"UTD.htm?41/14/42210\">",
"     image 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef58494 \" href=\"UTD.htm?38/55/39794\">",
"     movie 6",
"    </a>",
"    ) views of the membranous septum.",
"   </p>",
"   <p>",
"    Membranous defects may close spontaneously, either partially or completely, due to apposition of the septal leaflet of the tricuspid valve. In some cases, septal apposition results in an \"aneurysm of the ventricular septum,\" which is best seen in the parasternal long and short axis views but can be appreciated from multiple windows (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef64179 \" href=\"UTD.htm?11/35/11829\">",
"     image 6",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef51322 \" href=\"UTD.htm?11/13/11477\">",
"     movie 7",
"    </a>",
"    ). Color flow Doppler mapping is useful for establishing the presence of residual shunt flow through the \"aneurysm.\" Aneurysm formation most frequently begins in early infancy and may be associated with a decrease in size or spontaneous closure of even relatively large defects [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3096/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A number of associated findings may be seen with membranous VSDs, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Double chambered right ventricle, which refers to hypertrophy of the muscle bundles between the inlet and outlet portions of the right ventricle, resulting in mid chamber obstruction (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef52909 \" href=\"UTD.htm?17/37/18004\">",
"       image 7",
"      </a>",
"      and",
"      <a class=\"graphic graphic_movie graphicRef76939 \" href=\"UTD.htm?15/4/15428\">",
"       movie 8",
"      </a>",
"      ). These muscle bundles are particularly well seen in subcostal coronal and sagittal images, but may also be seen in parasternal short axis imaging in larger patients. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/19/8506?source=see_link&amp;anchor=H29#H29\">",
"       \"Pathophysiology and clinical features of isolated ventricular septal defects in infants and children\", section on 'RV outflow obstruction'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Left ventricular to right atrial shunt (via Gerbode defect), which may be demonstrated by two dimensional imaging, but is usually first suggested by color flow mapping demonstrating a high velocity jet originating in the crux of the heart in parasternal short axis, apical four chamber, or subcostal coronal images (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef53279 \" href=\"UTD.htm?12/49/13075\">",
"       image 8",
"      </a>",
"      and",
"      <a class=\"graphic graphic_movie graphicRef73264 \" href=\"UTD.htm?11/7/11379\">",
"       movie 9",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      A subaortic ridge and associated subaortic stenosis, which is an uncommon finding [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3096/abstract/9\">",
"       9",
"      </a>",
"      ]. Nevertheless, the left ventricular outflow tract should be carefully evaluated in parasternal long axis and apical images to rule out this abnormality.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Muscular defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Defects in the muscular septum are often multiple, especially if they are a complication of a myocardial infarction, and may be associated with defects in other regions of the septum. Color flow Doppler mapping is invaluable for detecting smaller defects that may be difficult to identify within the trabeculations of the right ventricle when only 2D transthoracic imaging is used; defects in the apical septum are the most likely to be missed (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75405 \" href=\"UTD.htm?9/47/9974\">",
"     image 9",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef62574 \" href=\"UTD.htm?8/0/8198\">",
"     movie 10",
"    </a>",
"    ). The septum should be interrogated carefully by sweeping the transducer from the right ventricular inflow to the left ventricular outflow tract in long axis and subcostal coronal images, sweeping through serial sections of the ventricle from apex to base in parasternal and parasagittal short axis imaging planes, and by sweeping from posterior to anterior in apical views.",
"   </p>",
"   <p>",
"    Color flow Doppler mapping is very helpful for identifying muscular defects, even at suboptimal angles of interrogation. However, in patients with increased right ventricular pressure, the color flow patterns for the flow velocity across these and all other types of VSDs become less apparent, decreasing the sensitivity of Doppler for their detection [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3096/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Supracristal defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Supracristal defects, sometimes referred to as subpulmonic or subpulmonary defects, are located caudal to the pulmonary valve and cephalad to the crista supraventricularis. Although they may be difficult to distinguish from membranous defects in the parasternal long axis view of 2D transthoracic echocardiography, they are often easily identified beneath the pulmonary valve in the parasternal short axis images obtained at the level of the arterial roots (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef63591 \" href=\"UTD.htm?38/3/38966\">",
"     image 10",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef54870 \" href=\"UTD.htm?36/34/37414\">",
"     movie 11",
"    </a>",
"    ). In younger patients, the relationship between the defect and the pulmonic valve can also be seen in the subcostal sagittal view (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef56498 \" href=\"UTD.htm?3/38/3686\">",
"     image 11",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef76408 \" href=\"UTD.htm?3/5/3158\">",
"     movie 12",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Prolapse of the unsupported right coronary cusp of the aortic valve into the defect may occur with supracristal VSDs and occasionally with perimembranous defects [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3096/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Associated prolapse of the noncoronary cusp occurs less commonly, may be associated with more significant aortic insufficiency and may be associated with a higher risk of failure of surgical repair [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3096/abstract/14\">",
"     14",
"    </a>",
"    ]. Prolapse of the leaflet into the defect is best observed in parasternal and subcostal long axis, and apical views (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82621 \" href=\"UTD.htm?1/13/1234\">",
"     image 12",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef69288 \" href=\"UTD.htm?42/53/43857\">",
"     movie 13",
"    </a>",
"    ). Although it can be difficult to appreciate the prolapse by transthoracic echocardiography, it is readily seen with TEE. Aortic valve regurgitation may occur with leaflet prolapse due to the progressive distortion of the leaflet; this distortion may be seen in parasternal short axis views of the aortic valve leaflets. The right coronary cusp deformation index and right coronary cusp imbalance indices may be used to quantify the degree of deformation. These indices correlate with the severity of aortic valve regurgitation and may be used in decisions regarding surgical intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3096/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Inlet defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inlet defects occur at the crux of the heart, posterior and inferior to membranous and outlet defects, and at the junction of the atrioventricular valves. Similar to other VSDs, inlet defects may be seen in many transthoracic echocardiographic imaging planes; however, these defects and their characteristic relationship to the atrioventricular valves are best demonstrated in apical and subcostal coronal views. The location of these defects in the posterior septum can be well seen in the parasternal short axis view (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef67011 \" href=\"UTD.htm?16/14/16609\">",
"     image 13",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef58066 \" href=\"UTD.htm?14/44/15041\">",
"     movie 14",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The relationship of the atrioventricular valves to the VSD must be carefully assessed. Tricuspid valve chordal attachments commonly insert on the crest or right ventricular surface of the septum. Anomalous chordal attachments of the mitral valve may also insert on the septum. In addition, either atrioventricular valve may straddle the defect, with chordal attachments crossing the defect and attaching anomalously on the septum or free wall of the opposite ventricle, complicating approaches to repair of the defect. It is important to assure that two atrioventricular valves are present, since these inlet VSDs may be part of a larger endocardial cushion defect.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Malalignment defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assessment of the relationship between the components of the ventricular septum and the atrial and ventricular septa must be included in the evaluation of a VSD. Malalignment defects occur when there is an abnormal relationship between the atrial and ventricular septa or between the individual components of the ventricular septa [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3096/abstract/11\">",
"     11",
"    </a>",
"    ]. Overriding and straddling atrioventricular valves are seen when there is malalignment of the atrial and ventricular septa. Malalignment of the conal septum, which partitions the great arteries and the trabecular septum dividing the ventricular chambers, may result in subaortic obstruction when there is posterior deviation of the conal septum. Aortic override with or without subpulmonary stenosis occurs when there is anterior deviation of the conal septum (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59821 \" href=\"UTD.htm?9/56/10112\">",
"     image 14",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef81875 \" href=\"UTD.htm?7/61/8144\">",
"     movie 15",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/27/13752?source=see_link\">",
"     \"Pathophysiology, clinical features, and diagnosis of tetralogy of Fallot\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     HEMODYNAMIC ASSESSMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to evaluating the anatomy of the VSD and its relationship to other cardiac structures, echocardiography also provides information about the hemodynamic abnormalities associated with the VSD, primarily the right and left ventricular pressures and the degree of shunting across the defect. The degree of shunting through a defect is influenced by the size of the defect and by the balance of resistances in the pulmonary and systemic circulations. The pressure and volume loads imposed by large VSDs result in elevations in pulmonary arterial pressure and resistance. Calculations of the ratio of pulmonary to systemic blood flow",
"    <span class=\"nowrap\">",
"     (Qp/Qs)",
"    </span>",
"    have less clinical utility than measurements of right ventricular and pulmonary arterial pressures, which reflect the effect of the VSD on the pulmonary vascular bed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Shunt determination",
"    </span>",
"    &nbsp;&mdash;&nbsp;2D imaging can give important qualitative information about the degree of shunting associated with the VSD. Both left atrial and left ventricular cavity dilation are present in VSDs that produce significant left-to-right shunting. Flow-related increases in transpulmonary and transmitral velocities, assessed by Doppler, may be documented in such lesions, while pulsed Doppler and Doppler color flow mapping can delineate the timing and direction of shunting during the cardiac cycle [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3096/abstract/16\">",
"     16",
"    </a>",
"    ]. Phase velocity mapping cardiac MRI is another quantitative approach for determining the pulmonic to systemic flows. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/3/34874?source=see_link&amp;anchor=H34#H34\">",
"     \"Clinical utility of cardiovascular magnetic resonance imaging\", section on 'Congenital heart disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In most individuals, left-to-right shunting predominates in mid and late diastole and throughout systole, while right-to-left shunting, which may not be clinically significant, is commonly seen in early diastole. However, with evolving pulmonary hypertension and pulmonary vascular disease, right-to-left shunting may occur in early and mid diastole, and even in late systole [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3096/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/19/8506?source=see_link\">",
"     \"Pathophysiology and clinical features of isolated ventricular septal defects in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The magnitude of left-to-right shunting at a ventricular septal defect can be estimated using any of several methods.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Traditionally, the ratio of pulmonary to systemic blood flow",
"      <span class=\"nowrap\">",
"       (Qp/Qs)",
"      </span>",
"      has been estimated using volumetric flow data, relying on measurements of aortic and pulmonary or mitral velocity or velocity time integrals, and corresponding luminal diameters or cross-sectional areas [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3096/abstract/18-22\">",
"       18-22",
"      </a>",
"      ]. Potential sources of error in this measurement include the limitations of lateral resolution in measurement of vessels and valve orifices, changes in the size of these structures during the cardiac cycle, suboptimal angle of Doppler interrogation, and the presence of turbulence in the pulmonary artery obscuring the Doppler outflow signal [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3096/abstract/23\">",
"       23",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/40/18054?source=see_link&amp;anchor=H2#H2\">",
"       \"Hemodynamics derived from transesophageal echocardiography\", section on 'Cardiac output'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Estimates of",
"      <span class=\"nowrap\">",
"       Qp/Qs",
"      </span>",
"      using color Doppler and flow convergence [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3096/abstract/23-26\">",
"       23-26",
"      </a>",
"      ] and of volumetric flow at the VSD have been shown to correlate with the measured",
"      <span class=\"nowrap\">",
"       Qp/Qs",
"      </span>",
"      in the cardiac catheterization laboratory. 3D echocardiographic measurements of the color Doppler imaged vena contracta and estimates of shunt flow ratio have also been shown to correlate with cardiac catheterization data [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3096/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Estimation of left ventricular end diastolic pressures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tissue Doppler indices, known to correlate with left ventricular end-diastolic pressure (LVEDP) in adults, have also been shown to reflect LVEDP in the setting of VSDs in children. In a study of children undergoing concurrent cardiac catheterization, an",
"    <span class=\"nowrap\">",
"     E/Ea",
"    </span>",
"    ratio greater than 9.8 was consistent with an LVEDP greater than 10 mmHg [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3096/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/45/7897?source=see_link&amp;anchor=H14#H14\">",
"     \"Tissue Doppler echocardiography\", section on 'Estimation of LV filling pressures'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Assessment of right ventricular and pulmonary artery pressures",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of methods can be used to estimate right ventricular and pulmonary artery pressures [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3096/abstract/29-32\">",
"     29-32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/0/15365?source=see_link&amp;anchor=H8#H8\">",
"     \"Principles of Doppler echocardiography\", section on 'Relationship between Doppler velocity and pressure gradient'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Using the modified Bernoulli equation (gradient [mmHg] = 4 x [peak velocity]",
"      <sup>",
"       2",
"      </sup>",
"      ), the maximum velocity of flow across the VSD, measured by Doppler at an optimal angle of interrogation, can be translated into the pressure gradient between the left and right ventricles (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef80947 \" href=\"UTD.htm?14/31/14839\">",
"       image 15",
"      </a>",
"      ). This value can then be subtracted from the patient's cuff pressure to estimate the systolic right ventricular and pulmonary arterial pressure [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3096/abstract/29\">",
"       29",
"      </a>",
"      ]. In the absence of coexistent right ventricular outflow tract obstruction, large gradients are seen in patients with smaller VSDs and low right ventricular pressures, and small gradients are seen in patients with elevated right ventricular and pulmonary arterial pressures. However, because of differences in the timing of activation of the left and right ventricles, this method may underestimate right ventricular pressure in some patients, most notably in those with an asymmetric or sloped Doppler waveform, where end systolic or mean gradient Doppler determinations may better reflect the pressure gradient across the ventricular septal defect [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3096/abstract/33,34\">",
"       33,34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The common findings of tricuspid and pulmonary regurgitation often allow estimation of right ventricular and pulmonary arterial pressures. Right ventricular systolic pressure can be estimated using the sum of the estimated right atrial pressure and the gradient between the right atrium and right ventricle as derived from the modified Bernoulli equation applied to the peak velocity of tricuspid regurgitation (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef58936 \" href=\"UTD.htm?39/60/40902\">",
"       image 16",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3096/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Mean and end diastolic pulmonary arterial pressures can be derived from analysis of the peak and end diastolic velocities of the pulmonary regurgitation jet, respectively (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef71753 \" href=\"UTD.htm?0/49/791\">",
"       image 17",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3096/abstract/31,32\">",
"       31,32",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the assessment of VSDs, these measurements of right ventricular and pulmonary artery pressures give crucial information regarding patient hemodynamics.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?4/26/4514?source=see_link\">",
"       \"Patient information: Ventricular septal defect (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4072759\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ventricular septal defects (VSD) are among the most common congenital cardiac abnormalities in the newborn, but are less commonly present in adults due to spontaneous closure of many muscular VSDs during childhood. VSD can also be an acquired disorder, such as those occurring after acute myocardial infarction. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Echocardiography is valuable not only in diagnosing VSDs, but also in the percutaneous and surgical treatment of these defects. Echocardiographic evaluation of VSDs includes identification of the number and location of defects, delineation of associated anatomic features, assessment of the size and hemodynamic significance of the defects, and guidance of interventional and surgical treatments. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Echocardiographic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      VSDs may occur in a variety of locations, including the membranous septum, muscular septum, supracristal area, and AV valve inlet area. Optimal echocardiographic imaging of defects in these different areas requires imaging from multiple sites as well as the use of color Doppler imaging. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Membranous VSD'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Muscular defects'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Supracristal defects'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6\">",
"       'Inlet defects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In addition to evaluating the anatomy of the VSD and its relationship to other cardiac structures, echocardiography also provides information about the hemodynamic abnormalities associated with the VSD, including the right and left ventricular pressures and the degree of shunting across the defect. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Hemodynamic assessment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/1\">",
"      Kardon RE, Cao QL, Masani N, et al. New insights and observations in three-dimensional echocardiographic visualization of ventricular septal defects: experimental and clinical studies. Circulation 1998; 98:1307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/2\">",
"      van den Bosch AE, Ten Harkel DJ, McGhie JS, et al. Feasibility and accuracy of real-time 3-dimensional echocardiographic assessment of ventricular septal defects. J Am Soc Echocardiogr 2006; 19:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/3\">",
"      Cheng TO, Xie MX, Wang XF, et al. Real-time 3-dimensional echocardiography in assessing atrial and ventricular septal defects: an echocardiographic-surgical correlative study. Am Heart J 2004; 148:1091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/4\">",
"      Mercer-Rosa L, Seliem MA, Fedec A, et al. Illustration of the additional value of real-time 3-dimensional echocardiography to conventional transthoracic and transesophageal 2-dimensional echocardiography in imaging muscular ventricular septal defects: does this have any impact on individual patient treatment? J Am Soc Echocardiogr 2006; 19:1511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/5\">",
"      Michel-Behnke I, Ewert P, Koch A, et al. Device closure of ventricular septal defects by hybrid procedures: a multicenter retrospective study. Catheter Cardiovasc Interv 2011; 77:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/6\">",
"      Mo X, Zuo W, Ma Z, et al. Hybrid procedure with cardiopulmonary bypass for muscular ventricular septal defects in children. Eur J Cardiothorac Surg 2011; 40:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/7\">",
"      Yang J, Yang L, Wan Y, et al. Transcatheter device closure of perimembranous ventricular septal defects: mid-term outcomes. Eur Heart J 2010; 31:2238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/8\">",
"      Miyake T, Shinohara T, Nakamura Y, et al. Aneurysm of the ventricular membranous septum: serial echocardiographic studies. Pediatr Cardiol 2004; 25:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/9\">",
"      Ero��lu AG, Oztun&ccedil; F, Saltik L, et al. Evolution of ventricular septal defect with special reference to spontaneous closure rate, subaortic ridge and aortic valve prolapse. Pediatr Cardiol 2003; 24:31.",
"     </a>",
"    </li>",
"    <li>",
"     Silverman NH. Pediatric Echocardiography, Williams &amp; Wilkins, Baltimore 1993. p.123.",
"    </li>",
"    <li>",
"     Snider AR, Serwer GA, Ritter SB. in Pediatric Heart Disease, Mosby, St Louis 1997. p.265.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/12\">",
"      Lun K, Li H, Leung MP, et al. Analysis of indications for surgical closure of subarterial ventricular septal defect without associated aortic cusp prolapse and aortic regurgitation. Am J Cardiol 2001; 87:1266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/13\">",
"      Graham TP, Kavanaugh-McHugh A. Ventricular septal defect and aortic regurgitation. Prog Pediatr Cardiol 2001; 14:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/14\">",
"      Tomita H, Arakaki Y, Ono Y, et al. Impact of noncoronary cusp prolapse in addition to right coronary cusp prolapse in patients with a perimembranous ventricular septal defect. Int J Cardiol 2005; 101:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/15\">",
"      Tomita H, Arakaki Y, Ono Y, et al. Severity indices of right coronary cusp prolapse and aortic regurgitation complicating ventricular septal defect in the outlet septum: which defect should be closed? Circ J 2004; 68:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/16\">",
"      Sommer RJ, Golinko RJ, Ritter SB. Intracardiac shunting in children with ventricular septal defect: evaluation with Doppler color flow mapping. J Am Coll Cardiol 1990; 16:1437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/17\">",
"      Stojni�� B, Pavlovi�� P, Ponomarev D, et al. Bidirectional shunt flow across a ventricular septal defect: pulsed Doppler echocardiographic analysis. Pediatr Cardiol 1995; 16:6.",
"     </a>",
"    </li>",
"    <li>",
"     Goldberg SJ, Allen HD, Marx GR, et al. Clinical application of Doppler Echocardiography to flow measurements. In: Doppler Echocardiography, Lea &amp; Febiger, Philadelphia 1985. p.92.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/19\">",
"      Sanders SP, Yeager S, Williams RG. Measurement of systemic and pulmonary blood flow and QP/QS ratio using Doppler and two-dimensional echocardiography. Am J Cardiol 1983; 51:952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/20\">",
"      Vargas Barron J, Sahn DJ, Valdes-Cruz LM, et al. Clinical utility of two-dimensional doppler echocardiographic techniques for estimating pulmonary to systemic blood flow ratios in children with left to right shunting atrial septal defect, ventricular septal defect or patent ductus arteriosus. J Am Coll Cardiol 1984; 3:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/21\">",
"      Cloez JL, Schmidt KG, Birk E, Silverman NH. Determination of pulmonary to systemic blood flow ratio in children by a simplified Doppler echocardiographic method. J Am Coll Cardiol 1988; 11:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/22\">",
"      Meijboom EJ, Horowitz S, Valdes-Cruz LM, et al. A simplified mitral valve method for two-dimensional echo Doppler blood flow calculation: validation in an open-chest canine model and initial clinical studies. Am Heart J 1987; 113:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/23\">",
"      Sabry AF, Reller MD, Silberbach GM, et al. Comparison of four Doppler echocardiographic methods for calculating pulmonary-to-systemic shunt flow ratios in patients with ventricular septal defect. Am J Cardiol 1995; 75:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/24\">",
"      Moises VA, Maciel BC, Hornberger LK, et al. A new method for noninvasive estimation of ventricular septal defect shunt flow by Doppler color flow mapping: imaging of the laminar flow convergence region on the left septal surface. J Am Coll Cardiol 1991; 18:824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/25\">",
"      Karr SS. New Doppler techniques for the evaluation of regurgitant and shunt volumes. Curr Opin Cardiol 1998; 13:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/26\">",
"      Kurotobi S, Sano T, Matsushita T, et al. Quantitative, non-invasive assessment of ventricular septal defect shunt flow by measuring proximal isovelocity surface area on colour Doppler mapping. Heart 1997; 78:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/27\">",
"      Ishii M, Hashino K, Eto G, et al. Quantitative assessment of severity of ventricular septal defect by three-dimensional reconstruction of color Doppler-imaged vena contracta and flow convergence region. Circulation 2001; 103:664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/28\">",
"      Oyamada J, Toyono M, Shimada S, et al. Noninvasive estimation of left ventricular end-diastolic pressure using tissue Doppler imaging combined with pulsed-wave Doppler echocardiography in patients with ventricular septal defects: a comparison with the plasma levels of the B-type natriuretic Peptide. Echocardiography 2008; 25:270.",
"     </a>",
"    </li>",
"    <li>",
"     Hatle I, Angelson B. Doppler ultrasound in cardiology. Physical principles and clinical applications, 2nd ed, Lea and Febiger, Philadelphia 1985. p.236.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/30\">",
"      Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984; 70:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/31\">",
"      Masuyama T, Kodama K, Kitabatake A, et al. Continuous-wave Doppler echocardiographic detection of pulmonary regurgitation and its application to noninvasive estimation of pulmonary artery pressure. Circulation 1986; 74:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/32\">",
"      Lee RT, Lord CP, Plappert T, Sutton MS. Prospective Doppler echocardiographic evaluation of pulmonary artery diastolic pressure in the medical intensive care unit. Am J Cardiol 1989; 64:1366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/33\">",
"      Schamberger MS, Farrell AG, Darragh RK, et al. Use of peak Doppler gradient across ventricular septal defects leads to underestimation of right-sided pressures in patients with \"sloped\" Doppler signals. J Am Soc Echocardiogr 2001; 14:1197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3096/abstract/34\">",
"      Lindblade CL, Schamberger MS, Darragh RK, Cordes TM. Use of peak Doppler gradient across ventricular septal defect leads to underestimation of right-sided pressures in a patient with M-shaped Doppler signal: a case report. J Am Soc Echocardiogr 2004; 17:1207.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5332 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-85249D4AE1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_1_3096=[""].join("\n");
var outline_f3_1_3096=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H4072759\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ECHOCARDIOGRAPHIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Membranous VSD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Muscular defects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Supracristal defects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Inlet defects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Malalignment defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      HEMODYNAMIC ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Shunt determination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Estimation of left ventricular end diastolic pressures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Assessment of right ventricular and pulmonary artery pressures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4072759\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/5332\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/5332|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?41/4/42052\" title=\"diagnostic image 1\">",
"      VSD closure device 2D and color still frame",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/36/14918\" title=\"diagnostic image 2\">",
"      Membranous VSD long axis color still frame",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?28/56/29574\" title=\"diagnostic image 3\">",
"      Membranous VSD short axis color still frame",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?20/55/21362\" title=\"diagnostic image 4\">",
"      Membranous VSD subcostal coronal 2D still frame",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?41/14/42210\" title=\"diagnostic image 5\">",
"      Membranous VSD subcostal parasagittal 2D still frame",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?11/35/11829\" title=\"diagnostic image 6\">",
"      Membranous VSD with aneurysm color still frame",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?17/37/18004\" title=\"diagnostic image 7\">",
"      Membranous VSD with double chambered RV still frame",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?12/49/13075\" title=\"diagnostic image 8\">",
"      Membranous VSD with LV to RA shunt still frame",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?9/47/9974\" title=\"diagnostic image 9\">",
"      Muscular VSD multiple color still frame",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?38/3/38966\" title=\"diagnostic image 10\">",
"      Supracristal VSD short axis 2D and color still frame",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?3/38/3686\" title=\"diagnostic image 11\">",
"      Supracristal VSD subcostal 2D and color still frame",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?1/13/1234\" title=\"diagnostic image 12\">",
"      VSD with prolapsed RCC of aortic valve still frame",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?16/14/16609\" title=\"diagnostic image 13\">",
"      Inlet VSD 4 chamber 2D still frame",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?9/56/10112\" title=\"diagnostic image 14\">",
"      VSD malalignment of long axis 2D still frame",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/31/14839\" title=\"diagnostic image 15\">",
"      VSD gradient CW Doppler",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?39/60/40902\" title=\"diagnostic image 16\">",
"      Tricuspid regurgitation CW Doppler",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?0/49/791\" title=\"diagnostic image 17\">",
"      Pulmonic regurgitation CW Doppler",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/5332|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?23/10/23720\" title=\"figure 1\">",
"      Anatomic location VSD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/5332|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?38/50/39716\" title=\"movie 1\">",
"      VSD closure device 2D and color",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?35/34/36388\" title=\"movie 2\">",
"      VSD closure device 2D",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?12/58/13222\" title=\"movie 3\">",
"      Membranous VSD long axis color",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?27/13/27862\" title=\"movie 4\">",
"      Membranous VSD short axis color",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?19/19/19762\" title=\"movie 5\">",
"      Membranous VSD subcostal coronal 2D",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?38/55/39794\" title=\"movie 6\">",
"      Membranous VSD subcostal parasagittal 2D",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?11/13/11477\" title=\"movie 7\">",
"      Membranous VSD with aneurysm color",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?15/4/15428\" title=\"movie 8\">",
"      Membranous VSD with double chambered RV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?11/7/11379\" title=\"movie 9\">",
"      Membranous VSD with LV to RA shunt",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?8/0/8198\" title=\"movie 10\">",
"      Muscular VSD multiple color",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?36/34/37414\" title=\"movie 11\">",
"      Supracristal VSD short axis 2D and color",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?3/5/3158\" title=\"movie 12\">",
"      Supracristal VSD subcostal 2D and color",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?42/53/43857\" title=\"movie 13\">",
"      VSD with prolapsed RCC of aortic valve",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?14/44/15041\" title=\"movie 14\">",
"      Inlet VSD 4 chamber 2D and color",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?7/61/8144\" title=\"movie 15\">",
"      VSD malalignment of long axis 2D",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/3/34874?source=related_link\">",
"      Clinical utility of cardiovascular magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/40/18054?source=related_link\">",
"      Hemodynamics derived from transesophageal echocardiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/19/39225?source=related_link\">",
"      Mechanical complications of acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/19/8506?source=related_link\">",
"      Pathophysiology and clinical features of isolated ventricular septal defects in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/27/13752?source=related_link\">",
"      Pathophysiology, clinical features, and diagnosis of tetralogy of Fallot",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/26/4514?source=related_link\">",
"      Patient information: Ventricular septal defect (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/0/15365?source=related_link\">",
"      Principles of Doppler echocardiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23146?source=related_link\">",
"      Three-dimensional echocardiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/45/7897?source=related_link\">",
"      Tissue Doppler echocardiography",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_1_3097="Invasive cardiac electrophysiology studies: Tachyarrhythmias";
var content_f3_1_3097=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Invasive cardiac electrophysiology studies: Tachyarrhythmias",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/1/3097/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/1/3097/contributors\">",
"     Philip J Podrid, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/1/3097/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/1/3097/contributors\">",
"     Peter J Zimetbaum, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/1/3097/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/1/3097/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/1/3097/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 1, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Invasive cardiac electrophysiology (EP) has rapidly evolved from a research tool to an established clinical technique for investigating and treating cardiac rhythm disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/1\">",
"     1",
"    </a>",
"    ]. The role of invasive cardiac electrophysiology studies in the diagnosis and management of patients with tachyarrhythmias will be reviewed here. An overview of cardiac electrophysiology, its role in the management of bradyarrhythmias, and the use of electrophysiologic mapping are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/2/12326?source=see_link\">",
"     \"Overview of invasive cardiac electrophysiology studies\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/51/22328?source=see_link\">",
"     \"Invasive cardiac electrophysiology studies: Bradyarrhythmias\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/42/27305?source=see_link\">",
"     \"Electrophysiologic cardiac mapping: Use in specific arrhythmias\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     NARROW QRS TACHYCARDIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;A narrow QRS tachycardia is almost always supraventricular in origin, and is generally not life threatening in the absence of structural heart disease. Thus, invasive EP studies are generally reserved for those patients with incapacitating symptoms, especially those patients being considered for transcatheter radiofrequency ablation.",
"   </p>",
"   <p>",
"    Even if pharmacologic therapy is preferred, however, there may still be a benefit in understanding the underlying mechanism to achieve optimal treatment. While the majority of narrow complex tachycardias can be diagnosed correctly as long as a 12-lead ECG is obtained during the supraventricular tachycardia (SVT), the incidence of correct diagnosis becomes nearly 100 percent after an invasive EP study. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/35/39481?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and evaluation of narrow QRS complex tachycardias\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Diagnostic EP may be indicated to determine the mechanism of the arrhythmia in the following patients with SVT:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Those with atrial fibrillation and typical or atypical atrial flutter when the ventricular response is regular, the QRS complex is wide, or exclusion of other diagnoses such as VT is needed. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/19/31034?source=see_link\">",
"       \"Approach to the diagnosis and treatment of wide QRS complex tachycardias\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Those with severe symptoms such as syncope or presyncope in association with the arrhythmia, particularly if the resting ECG manifests the pattern of preexcitation with a delta wave or a short PR interval without a delta wave (",
"      <a class=\"graphic graphic_waveform graphicRef63783 \" href=\"UTD.htm?41/5/42074\">",
"       waveform 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_waveform graphicRef75578 \" href=\"UTD.htm?34/55/35706\">",
"       waveform 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_waveform graphicRef67181 \" href=\"UTD.htm?38/39/39546\">",
"       waveform 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_waveform graphicRef76652 \" href=\"UTD.htm?42/58/43944\">",
"       waveform 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_waveform graphicRef74221 \" href=\"UTD.htm?38/52/39749\">",
"       waveform 5",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Those with underlying organic heart disease who develop angina or acute heart failure during their arrhythmia, even if the rate is relatively slow.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Techniques for supraventricular tachycardias",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electrode catheters typically are placed in the right atrium (RA), His bundle position, right ventricular apex, and coronary sinus (which records left atrial and ventricular electrograms). In patients with more complex SVT mechanisms, and in those undergoing mapping and transcatheter ablation, additional (usually deflectable) mapping catheters are added to locate the sites of earliest activity, or to record special potentials such as accessory pathway potentials, AV nodal slow pathway potentials, right bundle potential, or mid-diastolic potentials. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/23/39289?source=see_link\">",
"     \"Electrophysiologic cardiac mapping: Techniques\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/42/27305?source=see_link\">",
"     \"Electrophysiologic cardiac mapping: Use in specific arrhythmias\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Programmed atrial stimulation is usually from the high right atrium, although a second atrial site such as coronary sinus pacing is also employed in certain situations (",
"    <a class=\"graphic graphic_waveform graphicRef81938 \" href=\"UTD.htm?31/52/32585\">",
"     waveform 6",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. One or sometimes two atrial extrastimuli with progressively shorter coupling intervals are delivered following a train of eight or more drive beats at several cycle lengths until atrial refractoriness is encountered [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Incremental atrial pacing in steps of 10 msec is also performed until second degree AV block develops.",
"   </p>",
"   <p>",
"    Ventricular preexcitation may be unmasked during atrial premature stimulation or during administration of intravenous adenosine.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ventricular preexcitation in the presence of a fixed atrioventricular (AV) interval suggests an AV accessory pathway.",
"     </li>",
"     <li>",
"      Preexcitation occurring in association with progressively increasing AV delay with a greater degree of AH prolongation suggests a decremental, or Mahaim-type AV connection [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/5\">",
"       5",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17943?source=see_link\">",
"       \"Mahaim fiber tachycardias\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Demonstration of antegrade dual AV nodal pathways (a sudden increment in AH duration of &gt;50 msec in response to 10 to 20 msec shortening of the coupling interval) suggests an AV nodal reentrant tachycardia (AVNRT) (",
"      <a class=\"graphic graphic_waveform graphicRef60369 graphicRef72161 \" href=\"UTD.htm?34/2/34858\">",
"       waveform 7A-B",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24793?source=see_link\">",
"       \"Atrioventricular nodal reentrant tachycardia (junctional reciprocating tachycardia)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Even in the absence of preexcitation and dual pathway physiology, the pattern of decremental conduction through the AV node may show marked variation from one individual to the next. Localization of the site of critical delay required for the initiation of supraventricular tachycardia identifies the mechanism and the site of the tachycardia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Timing of electrophysiologic study in menstruating women",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many arrhythmias, including SVT, may be affected by phases in the menstrual cycle; premenstrual clustering of spontaneous arrhythmias has been observed [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/6\">",
"     6",
"    </a>",
"    ]. This phenomenon may be accompanied by variations in the ability to induce the arrhythmia during electrophysiologic testing. In one study of 42 women with SVT referred for electrophysiologic testing, 17 (40 percent) had a history of perimenstrual clustering of arrhythmia; six of these patients had a negative electrophysiologic study when performed midcycle but had SVT induced during a repeat study performed when premenstrual or at the onset of menses [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Tachycardia induced by atrial stimulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;When tachycardia is induced by atrial stimulation, several important observations and maneuvers can be used to diagnose the mechanism with certainty. However, one study of 196 patients with inducible SVT found that these diagnostic techniques rarely provide a diagnosis when used individually and multiple features and pacing maneuvers are often required for accurate diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      AV reentrant tachycardia (AVRT) requires an obligatory 1:1 P-to-QRS ratio and will not sustain in the presence of AV (or VA) block (",
"      <a class=\"graphic graphic_waveform graphicRef54720 \" href=\"UTD.htm?28/50/29478\">",
"       waveform 8",
"      </a>",
"      and",
"      <a class=\"graphic graphic_waveform graphicRef68804 \" href=\"UTD.htm?6/4/6217\">",
"       waveform 9",
"      </a>",
"      and",
"      <a class=\"graphic graphic_waveform graphicRef54484 \" href=\"UTD.htm?24/55/25464\">",
"       waveform 10",
"      </a>",
"      and",
"      <a class=\"graphic graphic_waveform graphicRef81938 \" href=\"UTD.htm?31/52/32585\">",
"       waveform 6",
"      </a>",
"      and",
"      <a class=\"graphic graphic_waveform graphicRef59861 \" href=\"UTD.htm?11/43/11954\">",
"       waveform 11",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39256?source=see_link\">",
"       \"Anatomy, pathophysiology and localization of accessory pathways in the preexcitation syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Sinus node reentry, atrial tachycardia due to intraatrial reentry (IART), and atrial flutter are likely to continue despite AV block (",
"      <a class=\"graphic graphic_waveform graphicRef63205 \" href=\"UTD.htm?23/14/23783\">",
"       waveform 12",
"      </a>",
"      and",
"      <a class=\"graphic graphic_waveform graphicRef68731 \" href=\"UTD.htm?10/18/10536\">",
"       waveform 13",
"      </a>",
"      and",
"      <a class=\"graphic graphic_waveform graphicRef82303 \" href=\"UTD.htm?3/44/3785\">",
"       waveform 14",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Atrioventricular nodal reentry also manifests a 1:1 AV ratio in the vast majority of cases. In rare cases, atria or ventricles may be dissociated from the tachycardia circuit (",
"      <a class=\"graphic graphic_waveform graphicRef70522 \" href=\"UTD.htm?1/21/1368\">",
"       waveform 15",
"      </a>",
"      and",
"      <a class=\"graphic graphic_waveform graphicRef57001 \" href=\"UTD.htm?38/58/39850\">",
"       waveform 16",
"      </a>",
"      and",
"      <a class=\"graphic graphic_waveform graphicRef81639 \" href=\"UTD.htm?38/48/39690\">",
"       waveform 17",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     P and QRS complexes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The relationship between the P and QRS complexes is also helpful in diagnosis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Simultaneous or nearly simultaneous P and QRS activation is seen with typical AVNRT (",
"      <a class=\"graphic graphic_waveform graphicRef57001 \" href=\"UTD.htm?38/58/39850\">",
"       waveform 16",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The P wave follows the QRS and is usually within the first half of the RR interval in AVRT and in certain forms of AVNRT.",
"     </li>",
"     <li>",
"      The P follows the QRS and may be in the second half of the RR interval in atypical AVNRT, and rarely in AVRT with a decrementally conducting retrograde pathway (",
"      <a class=\"graphic graphic_waveform graphicRef81639 \" href=\"UTD.htm?38/48/39690\">",
"       waveform 17",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Atrial activation sequence during tachycardia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The atrial activation sequence during the tachycardia often yields diagnostic information.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In sinus node reentrant tachycardia, a high-low and right-to-left atrial activation pattern is seen and is identical to the sinus beat.",
"     </li>",
"     <li>",
"      In IART, atrial activation will usually manifest a radial spread from the focus of arrhythmogenesis, which can be located practically anywhere in the atria.",
"     </li>",
"     <li>",
"      In typical AVNRT, the atrial activation is low-to-high septal with the site of earliest atrial activation at the anterior interatrial septum close to the site of His bundle recording.",
"     </li>",
"     <li>",
"      In atypical AVNRT, the atrial activation is also low to high, but with the site of earliest atrial activation observed close to or within the os of the coronary sinus or at posterocaudal interatrial septum.",
"     </li>",
"     <li>",
"      In orthodromic AVRT, the retrograde atrial activation is eccentric and originates at the site of atrial insertion of the accessory pathway (",
"      <a class=\"graphic graphic_figure graphicRef71302 \" href=\"UTD.htm?15/35/15926\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      In antidromic AVRT, the retrograde atrial activation is low to high and midline since VA conduction is usually, but not always, via the His-Purkinje and AV nodal tissue (",
"      <a class=\"graphic graphic_figure graphicRef50433 \" href=\"UTD.htm?34/52/35655\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Other features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other maneuvers and findings may also be of diagnostic help in patients with SVT.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The appearance of bundle branch block during SVT with an associated increase in the tachycardia cycle length and in the ventriculoatrial interval is diagnostic of an ipsilateral retrogradely conducting accessory pathway.",
"     </li>",
"     <li>",
"      Introduction of synchronized atrial or ventricular extrastimuli may further confirm the reentrant mechanism and site of the tachycardia. When properly timed, such extrastimuli will enter the reentrant circuit ahead of the circulating wave of activation and advance (reset) the tachycardia. During tachycardia, if a ventricular extrastimulus synchronized with His bundle depolarization (and hence added when this tissue is refractory) advances the following atrial electrogram and resets the SVT cycle, the presence of an extranodal atrioventricular connection is confirmed.",
"     </li>",
"     <li>",
"      The assessment of ventriculoatrial (VA) conduction is also important in the study of SVT. This is performed by ventricular extrastimulus and incremental ventricular pacing. Absence of VA conduction makes AVRT or AVNRT less likely and suggests an atrial tachycardia, since the latter is independent of retrograde VA conduction. If VA conduction recovers with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/23/11640?source=see_link\">",
"       atropine",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?22/31/23029?source=see_link\">",
"       isoproterenol",
"      </a>",
"      , AVNRT still remains a likely mechanism. Retrograde atrial activation during ventricular pacing may suggest accessory pathway presence if eccentric activation is noted, eg, left atrial activation prior to interatrial septal or right atrial activation.",
"     </li>",
"     <li>",
"      Administration of pharmacologic agents may be of help in certain settings. Selective blocking of retrograde AV nodal conduction with adenosine, for example, may unmask latent accessory pathway conduction. However, one study of patients with AVNRT found that not all patients developed retrograde AV nodal block with adenosine and therefore it may not reliably distinguish between retrograde conduction via the AV node or an accessory pathway [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/10\">",
"       10",
"      </a>",
"      ].",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/23/11640?source=see_link\">",
"       Atropine",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?22/31/23029?source=see_link\">",
"       isoproterenol",
"      </a>",
"      may be used to facilitate the induction of AVNRT or AVRT by enhancing VA conduction in patients with poorer AV nodal conduction characteristics [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/11\">",
"       11",
"      </a>",
"      ] or by widening the tachycardia zone or the section of the cardiac cycle during which extrastimuli cause the necessary block and the critical delay to initiate reentrant activation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     VENTRICULAR TACHYCARDIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a patient with documented or suspected VT, the decision to proceed with an invasive EP study, as well as the stimulation protocol to be used, depends upon the specific reason that the study is requested and the potential mechanism for the arrhythmia.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Electrophysiology may be useful as a diagnostic test for precise classification of a wide-complex tachycardia and to investigate the etiology of syncope or severely symptomatic palpitations when VT has not been documented but is suspected. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/19/31034?source=see_link\">",
"       \"Approach to the diagnosis and treatment of wide QRS complex tachycardias\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Therapeutically, VT induction and suppression of induced VT can be used as a guide for antiarrhythmic drug therapy, and may serve to reproduce previously documented clinical VT to assess the feasibility of nonpharmacologic therapies.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For each of these different indications, the utility of cardiac EP studies is also a function of the underlying heart disease. There are a number of noninvasive markers that may help predict inducibility of VT including late potentials on a signal-averaged ECG, left ventricular ejection fraction, and QT dispersion [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/12-15\">",
"     12-15",
"    </a>",
"    ]. Although any one factor may have low overall accuracy, the combination of increased QT dispersion, late potentials and reduced left ventricular ejection fraction had a specificity and sensitivity for inducibility of 78 and 75 percent, respectively in one report [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Techniques for VT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The standard procedure involves use of a bipolar pacing electrode positioned at the RV apex or RV outflow tract. The stimulation current used is twice the diastolic threshold value with a pulse width of 1 or 2 msec.",
"   </p>",
"   <p>",
"    Different protocols exist for ventricular stimulation studies. However, adequate protocols (90 percent sensitivity) for VT induction are those that use a basic drive train of at least eight captured beats, immediately followed by single, double, and if necessary triple ventricular extrastimuli that scan the electrical diastole (",
"    <a class=\"graphic graphic_waveform graphicRef60903 graphicRef60435 \" href=\"UTD.htm?25/44/26314\">",
"     waveform 18A-B",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/16\">",
"     16",
"    </a>",
"    ]. At least two drive trains, which differ by at least 20",
"    <span class=\"nowrap\">",
"     beats/minute,",
"    </span>",
"    are recommended for stimulation at the RV apex, followed by stimulation at the RV outflow tract. At least three drive trains at cycle lengths of 600, 500, and 400 msec are suggested if only the RV apex is being stimulated, although data suggest that the additional yield of a third cycle length after the first two cycle lengths is low [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other techniques also may be useful:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Left ventricular stimulation is an option, depending upon the clinical circumstances. It is more commonly used if the intention is to perform activation sequence mapping for nonpharmacologic therapy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/23/39289?source=see_link\">",
"       \"Electrophysiologic cardiac mapping: Techniques\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/42/27305?source=see_link\">",
"       \"Electrophysiologic cardiac mapping: Use in specific arrhythmias\"",
"      </a>",
"      .) Asynchronous ventricular burst pacing for VT induction is not recommended, although a possible role may exist for synchronous burst pacing, which is less likely to induce VF.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?22/31/23029?source=see_link\">",
"       Isoproterenol",
"      </a>",
"      infusion during ventricular stimulation may increase the yield of VT induction and thereby the sensitivity of the study [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/18,19\">",
"       18,19",
"      </a>",
"      ]. Isoproterenol is usually contraindicated in the presence of advanced coronary disease.",
"     </li>",
"     <li>",
"      Atrial pacing has been effective in VT induction in triggered VT and very rarely in reentrant VT [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/20,21\">",
"       20,21",
"      </a>",
"      ]. Maintaining the extrastimulus intervals at 180 msec or greater during ventricular stimulation is a commonly accepted precaution to minimize the incidence of inducing polymorphic VT or VF, which may be end points of low clinical relevance except in the patient with prehospital cardiac arrest [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In patients with advanced organic heart disease, it is common to induce several sustained monomorphic VTs with distinct surface ECG morphologies in the same patient (pleomorphism). Although pleomorphism of spontaneously recurrent VT is also a clinically observed phenomenon, the relationship between multiple clinical and multiple induced ECG morphologies has not been sufficiently investigated.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Reproducibility of VT induction by premature stimulation is variable, and is a function of the protocol, the particular arrhythmia induced, and the underlying heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/23-26\">",
"     23-26",
"    </a>",
"    ]. The short and long term reproducibility is generally high if two or three ventricular extrastimuli are used and if the patient has coronary heart disease. However, reproducibility in the absence of drug therapy may have little predictive importance, Data from the ESVEM trial suggested that the presence or absence of reproducibility had no effect on the incidence of drug efficacy based upon EP testing, the rate of arrhythmia recurrence, all-cause mortality, or cardiac or arrhythmic death [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The protocol for VT induction must not be rigid. It should be selected and modified depending primarily upon the clinical presentation (eg, monomorphic VT versus syncope), underlying heart disease (eg, ischemic heart disease versus no structural heart disease), and the indication for the study (eg, defining an end point for drug therapy versus nonpharmacologic intervention).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Management of VT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electrophysiologic testing has a primary role in the management of patients with recurrent sustained monomorphic VT or VF (",
"    <a class=\"graphic graphic_waveform graphicRef63176 \" href=\"UTD.htm?28/0/28680\">",
"     waveform 19",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef80454 \" href=\"UTD.htm?29/47/30455\">",
"     waveform 20",
"    </a>",
"    ). The EP study confirms the diagnosis, defines the degree of hemodynamic instability during VT, and provides invaluable data immediately relevant to specific therapy such as map-guided surgery, transcatheter ablation, and even implantable cardioverter-defibrillator (ICD) therapy. A programmed cardiac stimulation technique can also be used to assess the efficacy of antiarrhythmic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. Although not necessarily superior to pharmacologic therapy guided by electrocardiographic monitoring, EP guided therapy becomes pivotal in patients with little or no ambient ventricular ectopy who need an end point for demonstration of efficacy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/24/4490?source=see_link\">",
"     \"Evaluation of the survivor of sudden cardiac arrest\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Invasive EP studies with mapping are crucial if transcatheter ablation of a relatively slow and well-tolerated or incessant VT is being considered, or if an endocardial resection is contemplated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/23/39289?source=see_link\">",
"     \"Electrophysiologic cardiac mapping: Techniques\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/42/27305?source=see_link\">",
"     \"Electrophysiologic cardiac mapping: Use in specific arrhythmias\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cardiac EP studies may also provide useful and practical information regarding the choice of a particular device in patients undergoing ICD therapy. As an example, most of the available devices have tiered therapy capabilities, and the efficacy of specific responses such as low-energy cardioversion or antitachycardia pacing may be investigated by EP studies.",
"   </p>",
"   <p>",
"    Although over 90 percent of patients presenting with VT will have this arrhythmia induced by EP testing, only 60 to 70 percent of patients with VF have an inducible arrhythmia. Thus, patients who do not have inducible ventricular tachyarrhythmias at the baseline cardiac electrophysiology study are not necessarily at diminished risk for recurrence, especially if their heart function is depressed [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Cardiomyopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most of the available data about EP studies come from patients with underlying coronary artery disease and often a prior myocardial infarction. However, this technique has also been used in patients with other forms of heart disease. As an example, ventricular tachyarrhythmia is the major cause of sudden death in patients with hypertrophic cardiomyopathy (HCM) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. EP testing reveals a potpourri of rhythm disorders and conduction disturbances in these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/33\">",
"     33",
"    </a>",
"    ]. However, despite the good correlation between VT induction and the presenting symptoms of syncope or prehospital cardiac arrest, the specificity of other electrophysiologic disturbances is unknown. More importantly, there is no conclusive evidence supported by controlled data which suggests that suppression of inducible VT or VF in these patients improves prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    EP evaluation of patients with IDCM has shown that the clinical presentation is a major determinant of the response to premature stimulation; those who present with sustained monomorphic VT have the highest likelihood of having sustained monomorphic VT induced. In addition, the absence of induced sustained monomorphic VT has not been found to be a reliable negative predictor for subsequent arrhythmic events [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/35,36\">",
"     35,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    EP studies have also revealed that a significant proportion of patients with IDCM who have inducible sustained VT undergoing pharmacotherapy guided by serial programmed cardiac stimulation do not have their arrhythmias suppressed. Furthermore, not all investigations have shown a satisfactory event-free course during follow-up among those few patients whose ventricular arrhythmias were suppressed with an antiarrhythmic agent at the time of electrophysiologic testing [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/37-39\">",
"     37-39",
"    </a>",
"    ]. The reproducibility of the response to premature stimulation at baseline or after drug therapy is lower in patients with IDCM than in those with ischemic heart disease.",
"   </p>",
"   <p>",
"    One exception to this general lack of utility is in the diagnosis of VT based upon bundle branch reentry, an arrhythmia which can be permanently abolished by radiofrequency ablation of the right bundle branch (",
"    <a class=\"graphic graphic_waveform graphicRef67679 \" href=\"UTD.htm?32/12/32967\">",
"     waveform 21",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef75164 \" href=\"UTD.htm?4/55/4976\">",
"     figure 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_waveform graphicRef77331 \" href=\"UTD.htm?29/21/30035\">",
"     waveform 22",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/42/41637?source=see_link\">",
"     \"Bundle branch reentrant ventricular tachycardia\"",
"    </a>",
"    .) Bundle branch reentry may be responsible for as many as 33 percent of all monomorphic VT in patients with IDCM; a stimulation protocol that includes an abrupt cycle length change (from short to long) in the basic drive cycle just before the introduction of ventricular extrastimuli enhances its induction [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Structurally normal hearts",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electrophysiology testing has been described in the following patients with structurally normal hearts:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Programmed cardiac stimulation reproduces torsades de pointes in only about 10 patients with the congenital syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/43,44\">",
"       43,44",
"      </a>",
"      ]. As a result, EP testing does",
"      <strong>",
"       not",
"      </strong>",
"      play a significant role in the evaluation of patients with acquired or congenital long QT syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/44\">",
"       44",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/6/33897?source=see_link\">",
"       \"Diagnosis of congenital long QT syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Idiopathic LV tachycardia commonly, but not always, presents with right bundle branch block and left axis deviation on the surface 12-lead ECG; it can be terminated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"       verapamil",
"      </a>",
"      but not adenosine or vagal maneuvers [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/45,46\">",
"       45,46",
"      </a>",
"      ]. Atrial or ventricular pacing or ventricular extrastimuli commonly induces the tachycardia [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/20,47\">",
"       20,47",
"      </a>",
"      ]. Endocardial mapping during VT has localized the site of origin to the inferoapical portion of the LV in those patients with right bundle branch block and left axis deviation, and to the apical anteroseptal site in the few patients with right bundle branch block associated with right axis deviation (",
"      <a class=\"graphic graphic_figure graphicRef76252 \" href=\"UTD.htm?34/41/35474\">",
"       figure 4",
"      </a>",
"      ). Although the prognosis of this rhythm disorder is good and the long-term treatment with verapamil is effective, successful ablation of the VT site with RF energy has also been reported [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/48\">",
"       48",
"      </a>",
"      ]. Thus, the role of invasive cardiac electrophysiology studies in this form of VT is mostly related to ventricular mapping and transcatheter RF ablation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/14/26858?source=see_link&amp;anchor=H22#H22\">",
"       \"Monomorphic ventricular tachycardia in the absence of apparent structural heart disease\", section on 'Idiopathic left ventricular tachycardia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Catecholamine-sensitive VT (repetitive monomorphic ventricular tachycardia) is usually seen in the young patient and is frequently precipitated by exercise [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/49,50\">",
"       49,50",
"      </a>",
"      ]. The mechanism is thought to be triggered activity involving delayed afterdepolarizations. The afterdepolarizations are induced by an increase in the intracellular calcium concentration due to a variety of stimuli, including elevated plasma catecholamine levels. This type of VT typically presents with left bundle branch block and an inferiorly directed frontal axis on the surface ECG, reflecting its usual site of origin in the right ventricular outflow tract. The role of cardiac EP studies is related primarily to the feasibility of potentially curable nonpharmacologic therapy. Catecholamine-sensitive VT can usually be reproduced in the EP laboratory and catheter mapped with a high degree of safety and precision.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?22/31/23029?source=see_link\">",
"       Isoproterenol",
"      </a>",
"      infusion alone frequently initiates VT, or transforms nonsustained to sustained episodes; programmed stimulation can also succeed in tachycardia induction either by rapid atrial stimulation, rapid ventricular stimulation, or ventricular extrastimuli [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/50\">",
"       50",
"      </a>",
"      ]. Successful ablation of this VT has been reported with direct current shock and, more recently, RF energy [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3097/abstract/51-54\">",
"       51-54",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/14/26858?source=see_link&amp;anchor=H9#H9\">",
"       \"Monomorphic ventricular tachycardia in the absence of apparent structural heart disease\", section on 'Repetitive monomorphic VT'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The role of invasive EP studies in the management of other rare forms of VTs, such as the ones associated with arrhythmogenic RV dysplasia, scleroderma, and sarcoidosis, is uncertain. Clinical data on these forms are available from case reports or small series, and the utility of invasive electrophysiology studies in their management needs further clarification.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6565326\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Invasive electrophysiology (EP) studies are generally reserved for those patients with incapacitating symptoms, especially those patients being considered for transcatheter radiofrequency ablation. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Narrow QRS tachycardia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      During EP studies for suspected supraventricular tachycardias, electrode catheters typically are placed in the right atrium (RA), His bundle position, right ventricular apex, and coronary sinus (which records left atrial and ventricular electrograms). Programmed atrial stimulation is usually from the high right atrium, although a second atrial site such as coronary sinus pacing is also employed in certain situations. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Techniques for supraventricular tachycardias'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When tachycardia is induced by atrial stimulation, several important observations and maneuvers can be used to diagnose the mechanism with certainty. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Tachycardia induced by atrial stimulation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      EP studies may be useful as a diagnostic test for precise classification of a wide-complex tachycardia and to investigate the etiology of syncope or severely symptomatic palpitations when ventricular tachycardia (VT) has not been documented but is suspected. Additionally, EP studies may be performed prior to therapeutic intervention (ie, catheter ablation) for VT. Although not a common indication, EP studies may be helpful for establishing an effective antiarrhythmic agent when other types of therapy are not indicated or effective. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Ventricular tachycardia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      During EP studies for suspected VT, the standard procedure involves use of a bipolar pacing electrode positioned at the RV apex or RV outflow tract, with different protocols for ventricular stimulation. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Techniques for VT'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/1\">",
"      Rahimtoola SH, Zipes DP, Akhtar M, et al. Consensus statement of the Conference on the State of the Art of Electrophysiologic Testing in the Diagnosis and Treatment of Patients with Cardiac Arrhythmias. Circulation 1987; 75:III3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/2\">",
"      Wellens HJ, Brugada P, B&auml;r FW. Indications for use of intracardiac electrophysiologic studies for the diagnosis of site of origin and mechanism of tachycardias. Circulation 1987; 75:III110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/3\">",
"      Brugada P, Farr&eacute; J, Green M, et al. Observations in patients with supraventricular tachycardia having a P-R interval shorter than the R-P interval: differentiation between atrial tachycardia and reciprocating atrioventricular tachycardia using an accessory pathway with long conduction times. Am Heart J 1984; 107:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/4\">",
"      Denes P, Wu D, Amat-y-Leon F, et al. The determinants of atrioventricular nodal re-entrance with premature atrial stimulation in patients with dual A-V nodal pathways. Circulation 1977; 56:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/5\">",
"      Gallagher JJ, Smith WM, Kasell JH, et al. Role of Mahaim fibers in cardiac arrhythmias in man. Circulation 1981; 64:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/6\">",
"      Rosano GM, Leonardo F, Sarrel PM, et al. Cyclical variation in paroxysmal supraventricular tachycardia in women. Lancet 1996; 347:786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/7\">",
"      Myerburg RJ, Cox MM, Interian A Jr, et al. Cycling of inducibility of paroxysmal supraventricular tachycardia in women and its implications for timing of electrophysiologic procedures. Am J Cardiol 1999; 83:1049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/8\">",
"      Knight BP, Ebinger M, Oral H, et al. Diagnostic value of tachycardia features and pacing maneuvers during paroxysmal supraventricular tachycardia. J Am Coll Cardiol 2000; 36:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/9\">",
"      Akhtar M, Damato AN, Ruskin JN, et al. Antegrade and retrograde conduction characteristics in three patterns of paroxysmal atrioventricular junctional reentrant tachycardia. Am Heart J 1978; 95:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/10\">",
"      Fishberger SB, Mehta D, Rossi AF, et al. Variable effects of adenosine on retrograde conduction in patients with atrioventricular nodal reentry tachycardia. Pacing Clin Electrophysiol 1998; 21:1254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/11\">",
"      Yu WC, Chen SA, Chiang CE, et al. Effects of isoproterenol in facilitating induction of slow-fast atrioventricular nodal reentrant tachycardia. Am J Cardiol 1996; 78:1299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/12\">",
"      Nalos PC, Gang ES, Mandel WJ, et al. The signal-averaged electrocardiogram as a screening test for inducibility of sustained ventricular tachycardia in high risk patients: a prospective study. J Am Coll Cardiol 1987; 9:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/13\">",
"      Martinez-Rubio A, Shenasa M, Borggrefe M, et al. Electrophysiologic variables characterizing the induction of ventricular tachycardia versus ventricular fibrillation after myocardial infarction: relation between ventricular late potentials and coupling intervals for the induction of sustained ventricular tachyarrhythmias. J Am Coll Cardiol 1993; 21:1624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/14\">",
"      Steinberg JS, Prystowsky E, Freedman RA, et al. Use of the signal-averaged electrocardiogram for predicting inducible ventricular tachycardia in patients with unexplained syncope: relation to clinical variables in a multivariate analysis. J Am Coll Cardiol 1994; 23:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/15\">",
"      Lee KW, Okin PM, Kligfield P, et al. Precordial QT dispersion and inducible ventricular tachycardia. Am Heart J 1997; 134:1005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/16\">",
"      Waldo AL, Akhtar M, Brugada P, et al. The minimally appropriate electrophysiologic study for the initial assessment of patients with documented sustained monomorphic ventricular tachycardia. J Am Coll Cardiol 1985; 6:1174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/17\">",
"      Estes NA 3rd, Garan H, McGovern B, Ruskin JN. Influence of drive cycle length during programmed stimulation on induction of ventricular arrhythmias: analysis of 403 patients. Am J Cardiol 1986; 57:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/18\">",
"      Reddy CP, Gettes LS. Use of isoproterenol as an aid to electric induction of chronic recurrent ventricular tachycardia. Am J Cardiol 1979; 44:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/19\">",
"      Freedman RA, Swerdlow CD, Echt DS, et al. Facilitation of ventricular tachyarrhythmia induction by isoproterenol. Am J Cardiol 1984; 54:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/20\">",
"      German LD, Packer DL, Bardy GH, Gallagher JJ. Ventricular tachycardia induced by atrial stimulation in patients without symptomatic cardiac disease. Am J Cardiol 1983; 52:1202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/21\">",
"      Zipes DP, Foster PR, Troup PJ, Pedersen DH. Atrial induction of ventricular tachycardia: reentry versus triggered automaticity. Am J Cardiol 1979; 44:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/22\">",
"      Morady F, DiCarlo LA Jr, Baerman JM, de Buitleir M. Comparison of coupling intervals that induce clinical and nonclinical forms of ventricular tachycardia during programmed stimulation. Am J Cardiol 1986; 57:1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/23\">",
"      Mann DE, Hartz V, Hahn EA, Reiter MJ. Effect of reproducibility of baseline arrhythmia induction on drug efficacy predictions and outcome in the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) trial. Am J Cardiol 1997; 80:1448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/24\">",
"      Kudenchuk PJ, Kron J, Walance CG, et al. Reproducibility of arrhythmia induction with intracardiac electrophysiologic testing: patients with clinical sustained ventricular tachyarrhythmias. J Am Coll Cardiol 1986; 7:819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/25\">",
"      Schoenfeld MH, McGovern B, Garan H, Ruskin JN. Long-term reproducibility of responses to programmed cardiac stimulation in spontaneous ventricular tachyarrhythmias. Am J Cardiol 1984; 54:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/26\">",
"      Lombardi F, Stein J, Podrid PJ, et al. Daily reproducibility of electrophysiologic test results in malignant ventricular arrhythmia. Am J Cardiol 1986; 57:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/27\">",
"      Prystowsky EN. Electrophysiologic-electropharmacologic testing in patients with ventricular arrhythmias. Pacing Clin Electrophysiol 1988; 11:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/28\">",
"      Kuchar DL, Garan H, Ruskin JN. Electrophysiologic evaluation of antiarrhythmic therapy for ventricular tachyarrhythmias. Am J Cardiol 1988; 62:39H.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/29\">",
"      Morady F, DiCarlo L, Winston S, et al. Clinical features and prognosis of patients with out of hospital cardiac arrest and a normal electrophysiologic study. J Am Coll Cardiol 1984; 4:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/30\">",
"      Roy D, Waxman HL, Kienzle MG, et al. Clinical characteristics and long-term follow-up in 119 survivors of cardiac arrest: relation to inducibility at electrophysiologic testing. Am J Cardiol 1983; 52:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/31\">",
"      McKenna WJ, Camm AJ. Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk. Circulation 1989; 80:1489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/32\">",
"      Nicod P, Polikar R, Peterson KL. Hypertrophic cardiomyopathy and sudden death. N Engl J Med 1988; 318:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/33\">",
"      Fananapazir L, Tracy CM, Leon MB, et al. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients. Circulation 1989; 80:1259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/34\">",
"      Fananapazir L, Chang AC, Epstein SE, McAreavey D. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Circulation 1992; 86:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/35\">",
"      Brembilla-Perrot B, Donetti J, de la Chaise AT, et al. Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy. Am Heart J 1991; 121:1124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/36\">",
"      Liem LB, Swerdlow CD. Value of electropharmacologic testing in idiopathic dilated cardiomyopathy and sustained ventricular tachyarrhythmias. Am J Cardiol 1988; 62:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/37\">",
"      Constantin L, Martins JB, Kienzle MG, et al. Induced sustained ventricular tachycardia in nonischemic dilated cardiomyopathy: dependence on clinical presentation and response to antiarrhythmic agents. Pacing Clin Electrophysiol 1989; 12:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/38\">",
"      Milner PG, Dimarco JP, Lerman BB. Electrophysiological evaluation of sustained ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol 1988; 11:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/39\">",
"      Poll DS, Marchlinski FE, Buxton AE, Josephson ME. Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol 1986; 58:992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/40\">",
"      Caceres J, Jazayeri M, McKinnie J, et al. Sustained bundle branch reentry as a mechanism of clinical tachycardia. Circulation 1989; 79:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/41\">",
"      Tchou P, Jazayeri M, Denker S, et al. Transcatheter electrical ablation of right bundle branch. A method of treating macroreentrant ventricular tachycardia attributed to bundle branch reentry. Circulation 1988; 78:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/42\">",
"      Denker S, Lehmann M, Mahmud R, et al. Facilitation of ventricular tachycardia induction with abrupt changes in ventricular cycle length. Am J Cardiol 1984; 53:508.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/43\">",
"      Garson A Jr, Dick M 2nd, Fournier A, et al. The long QT syndrome in children. An international study of 287 patients. Circulation 1993; 87:1866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/44\">",
"      Bhandari AK, Shapiro WA, Morady F, et al. Electrophysiologic testing in patients with the long QT syndrome. Circulation 1985; 71:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/45\">",
"      Belhassen B, Shapira I, Pelleg A, et al. Idiopathic recurrent sustained ventricular tachycardia responsive to verapamil: an ECG-electrophysiologic entity. Am Heart J 1984; 108:1034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/46\">",
"      Lin FC, Finley CD, Rahimtoola SH, Wu D. Idiopathic paroxysmal ventricular tachycardia with a QRS pattern of right bundle branch block and left axis deviation: a unique clinical entity with specific properties. Am J Cardiol 1983; 52:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/47\">",
"      Ohe T, Shimomura K, Aihara N, et al. Idiopathic sustained left ventricular tachycardia: clinical and electrophysiologic characteristics. Circulation 1988; 77:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/48\">",
"      Klein LS, Shih HT, Hackett FK, et al. Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease. Circulation 1992; 85:1666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/49\">",
"      Lerman BB, Belardinelli L, West GA, et al. Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity. Circulation 1986; 74:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/50\">",
"      Buxton AE, Waxman HL, Marchlinski FE, et al. Right ventricular tachycardia: clinical and electrophysiologic characteristics. Circulation 1983; 68:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/51\">",
"      Morady F, Kadish AH, DiCarlo L, et al. Long-term results of catheter ablation of idiopathic right ventricular tachycardia. Circulation 1990; 82:2093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/52\">",
"      Breithardt G, Borggrefe M, Wichter T. Catheter ablation of idiopathic right ventricular tachycardia. Circulation 1990; 82:2273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/53\">",
"      Wilber DJ, Baerman J, Olshansky B, et al. Adenosine-sensitive ventricular tachycardia. Clinical characteristics and response to catheter ablation. Circulation 1993; 87:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3097/abstract/54\">",
"      Calkins H, Kalbfleisch SJ, el-Atassi R, et al. Relation between efficacy of radiofrequency catheter ablation and site of origin of idiopathic ventricular tachycardia. Am J Cardiol 1993; 71:827.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 978 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-60.18.131.125-92069A6D88-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_1_3097=[""].join("\n");
var outline_f3_1_3097=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H6565326\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      NARROW QRS TACHYCARDIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Techniques for supraventricular tachycardias",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Timing of electrophysiologic study in menstruating women",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Tachycardia induced by atrial stimulation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - P and QRS complexes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Atrial activation sequence during tachycardia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Other features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      VENTRICULAR TACHYCARDIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Techniques for VT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Management of VT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Structurally normal hearts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6565326\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/978\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/978|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/35/15926\" title=\"figure 1\">",
"      Orthodromic AVRT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/52/35655\" title=\"figure 2\">",
"      Antidromic AVRT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/55/4976\" title=\"figure 3\">",
"      Mechanism of bundle branch reentrant ventricular tachycardia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?34/41/35474\" title=\"figure 4\">",
"      Noncontact map fascicular tachy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/978|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?41/5/42074\" title=\"waveform 1\">",
"      ECG Wolff-Parkinson-White syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?34/55/35706\" title=\"waveform 2\">",
"      ECG WPW tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?38/39/39546\" title=\"waveform 3\">",
"      12 lead WPW",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?42/58/43944\" title=\"waveform 4\">",
"      ECG Lown-Ganong-Levine syndrome tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?38/52/39749\" title=\"waveform 5\">",
"      Lown Ganong Levine ECG",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?31/52/32585\" title=\"waveform 6\">",
"      EPS tracing AVRT initiation termination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?5/34/5672\" title=\"waveform 7A\">",
"      EPS tracing AVNRT dual AVN pathways I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?6/2/6184\" title=\"waveform 7B\">",
"      EPS tracing AVNRT dual AVN pathways II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?28/50/29478\" title=\"waveform 8\">",
"      Orthodromic AVRT tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?6/4/6217\" title=\"waveform 9\">",
"      12 lead ECG orthodromic AVRT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?24/55/25464\" title=\"waveform 10\">",
"      12 lead ECG antidromic AVRT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?11/43/11954\" title=\"waveform 11\">",
"      Electrograms AVRT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?23/14/23783\" title=\"waveform 12\">",
"      Sinus node reentry tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?10/18/10536\" title=\"waveform 13\">",
"      Atrial tach with block tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?3/44/3785\" title=\"waveform 14\">",
"      ECG atrial flutter tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?1/21/1368\" title=\"waveform 15\">",
"      AVN reentrant tach tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?38/58/39850\" title=\"waveform 16\">",
"      12 lead ECG common AVNRT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?38/48/39690\" title=\"waveform 17\">",
"      12 lead ECG uncommon AVNRT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?12/59/13241\" title=\"waveform 18A\">",
"      EPS tracing VT initiation termination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?18/32/18947\" title=\"waveform 18B\">",
"      Electrograms ventricular tachy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?28/0/28680\" title=\"waveform 19\">",
"      ECG Monomorphic VT tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?29/47/30455\" title=\"waveform 20\">",
"      ECG Ventricular fibrillation tutorial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?32/12/32967\" title=\"waveform 21\">",
"      ECG bundle branch reentrant ventricular tachcardia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?29/21/30035\" title=\"waveform 22\">",
"      EP study tracings bundle branch reentrant VT",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39256?source=related_link\">",
"      Anatomy, pathophysiology and localization of accessory pathways in the preexcitation syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/19/31034?source=related_link\">",
"      Approach to the diagnosis and treatment of wide QRS complex tachycardias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24793?source=related_link\">",
"      Atrioventricular nodal reentrant tachycardia (junctional reciprocating tachycardia)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/42/41637?source=related_link\">",
"      Bundle branch reentrant ventricular tachycardia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/35/39481?source=related_link\">",
"      Clinical manifestations, diagnosis, and evaluation of narrow QRS complex tachycardias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/6/33897?source=related_link\">",
"      Diagnosis of congenital long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/23/39289?source=related_link\">",
"      Electrophysiologic cardiac mapping: Techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/42/27305?source=related_link\">",
"      Electrophysiologic cardiac mapping: Use in specific arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/24/4490?source=related_link\">",
"      Evaluation of the survivor of sudden cardiac arrest",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/51/22328?source=related_link\">",
"      Invasive cardiac electrophysiology studies: Bradyarrhythmias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17943?source=related_link\">",
"      Mahaim fiber tachycardias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/14/26858?source=related_link\">",
"      Monomorphic ventricular tachycardia in the absence of apparent structural heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/2/12326?source=related_link\">",
"      Overview of invasive cardiac electrophysiology studies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_1_3098="Hematologic manifestations of HIV infection: Anemia";
var content_f3_1_3098=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Hematologic manifestations of HIV infection: Anemia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/1/3098/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/1/3098/contributors\">",
"     Timothy J Friel, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/1/3098/contributors\">",
"     David T Scadden, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/1/3098/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/1/3098/contributors\">",
"     Stanley L Schrier, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?3/1/3098/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?3/1/3098/contributors\">",
"     Stephen A Landaw, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?3/1/3098/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Shortly after the first description of the acquired immunodeficiency syndrome (AIDS), cytopenias of all major blood cell lines were increasingly recognized in patients with HIV infection. As an example, in one early series of patients with AIDS, anemia was noted in approximately 70 percent, lymphopenia in 70 percent, neutropenia in 50 percent, and thrombocytopenia in 40 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incidence of the various cytopenias correlates directly with the degree of immunosuppression. However, isolated abnormalities, particularly thrombocytopenia, may be encountered as the initial presentation of human immunodeficiency virus (HIV) infection. As a result, HIV infection should be considered in the assessment of patients presenting with any type of cytopenia.",
"   </p>",
"   <p>",
"    The causes and treatment of anemia in patients with HIV infection will be reviewed here. Similar issues regarding neutropenia, thrombocytopenia, coagulation defects, and lymphopenia are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/0/44039?source=see_link\">",
"     \"Hematologic manifestations of HIV infection: Neutropenia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/11/14522?source=see_link\">",
"     \"Hematologic manifestations of HIV infection: Thrombocytopenia and coagulation abnormalities\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/52/21320?source=see_link\">",
"     \"Techniques and interpretation of measurement of the CD4 cell count in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INCIDENCE AND SIGNIFICANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anemia is the most common hematologic abnormality associated with HIV infection, affecting 60 to 80 percent of patients in late stage disease. While anemia may manifest as a mere laboratory abnormality in some individuals, others may experience typical symptoms (eg, fatigue, dyspnea, reduced exercise tolerance, diminished functional capacity) directly related to a reduction in hemoglobin concentration. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29418?source=see_link\">",
"     \"Approach to the adult patient with anemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a review of more than 32,000 patients infected with HIV, the yearly incidence of developing anemia increased with disease progression, affecting 3 percent of all patients with asymptomatic HIV infection, 12 percent of asymptomatic patients with CD4 cell counts",
"    <span class=\"nowrap\">",
"     &lt;200/microL,",
"    </span>",
"    and 37 percent of patients with an AIDS-related illness [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk factors for the development of anemia were evaluated in a report from The Women's Interagency HIV study (WIHS), which evaluated 2056 HIV-1 infected women between October 1994 and September 1998 for the development of anemia (ie, Hgb &lt;12",
"    <span class=\"nowrap\">",
"     g/dL)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/3\">",
"     3",
"    </a>",
"    ]. Four risk factors were identified:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Mean corpuscular volume (MCV) &lt;80 fL &mdash; OR 4.2 (95% CI 2.8-6.2)",
"     </li>",
"     <li>",
"      CD4 count",
"      <span class=\"nowrap\">",
"       &lt;200/microL",
"      </span>",
"      &mdash; OR 2.0 (95% CI 1.6-2.4)",
"     </li>",
"     <li>",
"      HIV-1 viral load",
"      <span class=\"nowrap\">",
"       &ge;50,000/mL",
"      </span>",
"      &mdash; OR 1.7 (95% CI 1.4-2.1)",
"     </li>",
"     <li>",
"      Use of AZT in past six months &mdash; OR 1.7 (95% CI 1.4-2.0)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Effect on mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of anemia is associated with increased morbidity and mortality in both children and adults with HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/3-8\">",
"     3-8",
"    </a>",
"    ]. In the above review of 32,000 patients seen prior to the advent of highly active antiretroviral therapy (HAART), anemia was significantly associated with an increased risk of death when patients were stratified by CD4 cell counts [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/2\">",
"     2",
"    </a>",
"    ]. Furthermore, mortality rates fell in those who recovered from the anemia to a level comparable to patients who were not anemic; this effect was independent of the CD4 cell count [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/2\">",
"     2",
"    </a>",
"    ]. In another study involving more than 1000 HIV-infected Tanzanian women, anemia was associated with increased AIDS-related and all-cause mortality, independent of baseline CD4 count, World Health Organization clinical stage, patient age, and body mass index [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the advent of HAART, HIV-related anemia is still common, and independently associated with decreased survival [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/3,6,9,10\">",
"     3,6,9,10",
"    </a>",
"    ]. In a European study of 6725 HIV-infected patients with a one year follow-up, the incidence of mild (hemoglobin 8 to 14",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    in men and 8 to 12 in women) and severe (hemoglobin &lt;8",
"    <span class=\"nowrap\">",
"     g/dL)",
"    </span>",
"    anemia was 58 and 1.4 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/10\">",
"     10",
"    </a>",
"    ]. The death rate at one year for this cohort was 3, 16, and 41 percent for those who had no, mild, or severe anemia, respectively.",
"   </p>",
"   <p>",
"    Similar findings were noted in the WIHS study [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/3\">",
"     3",
"    </a>",
"    ]. Anemia was independently associated with decreased survival (hazard ratio 2.6, 95% CI 1.9-3.4) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Effect of HAART'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In most cases, the cause of anemia in HIV-infected patients is",
"    <strong>",
"     multifactorial",
"    </strong>",
"    , reflecting the associated and often additive effects of infection, malignancy, malnutrition, and polypharmacy (",
"    <a class=\"graphic graphic_table graphicRef65608 \" href=\"UTD.htm?24/50/25388\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/2\">",
"     2",
"    </a>",
"    ]. The finding of a low hematocrit or hemoglobin concentration warrants careful evaluation for treatable underlying illnesses, including a complete blood count with red cell indices and reticulocyte count, serum bilirubin and vitamin B12, red cell folate levels, iron studies, peripheral blood smear and, in cases of refractory or unexplained anemia, serum erythropoietin and bone marrow sampling. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29418?source=see_link\">",
"     \"Approach to the adult patient with anemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Opportunistic processes must be carefully excluded during the evaluation of anemia. Although many infections may be associated with cytopenias in HIV-infected patients, several are characteristically linked to abnormalities of red blood cell production. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/42/33450?source=see_link&amp;anchor=H2#H2\">",
"     \"Primary prevention of opportunistic infections in HIV-infected patients\", section on 'Epidemiology of opportunistic infections'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Mycobacteria, fungi, and parasites",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mycobacteria and fungi are capable of broad dissemination throughout the bone marrow, eventually replacing the normal architecture and inhibiting the maturation of progenitor cells. Mycobacterium avium complex (MAC), M. tuberculosis, and Histoplasma capsulatum are the most common offenders. In more rare cases, other agents such as Pneumocystis carinii, Cryptococcus neoformans, and Penicillium marneffei have caused pancytopenia through bone marrow infiltration [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Visceral leishmaniasis is another cause of significant anemia among HIV patients living in endemic areas.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Viral infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral infections may be associated with suppression of normal bone marrow function. Mild-to-moderate anemia is a common finding in patients with acute cytomegalovirus (CMV) or Epstein-Barr virus (EBV) infection in addition to HIV.",
"   </p>",
"   <p>",
"    Parvovirus B19 is a small, single-stranded DNA virus capable of infecting and lysing early erythroid precursors. In the normal host, the immune response controls the infection in 10 days to two weeks, red cell production returns, and there is no clinically apparent anemia. However, a potentially life-threatening anemia can occur in immunodeficient patients due to an inability to control the virus. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22377?source=see_link\">",
"     \"Clinical manifestations and pathogenesis of human parvovirus B19 infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although parvovirus B19 has been linked to the development of chronic and often severe anemia in patients with HIV infection, persistent viremia with parvovirus appears to be a rare occurrence. In one study, for example, sera from 317 consecutive HIV-positive patients were evaluated, 55 percent of whom were anemic [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/12\">",
"     12",
"    </a>",
"    ]. Over 60 percent had detectable IgG reacting to parvovirus B19, but none had detectable viral DNA by polymerase chain reaction [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, the likelihood of parvovirus B19 viremia is increased when only patients with severe anemia are analyzed [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. In one series, PCR analysis for parvoviral DNA was positive in 17 and 31 percent of HIV-infected patients with hematocrits &le;24 and &le;20 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Malignancy and lymphoproliferative disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infiltration of the bone marrow by malignant cells is a potential cause of anemia and other cytopenias. The small noncleaved cell type of non-Hodgkin lymphoma is the most common offender (Burkitt-like), followed by other aggressive and highly aggressive malignant lymphomas and, rarely, Kaposi's sarcoma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/4/7242?source=see_link&amp;anchor=H10#H10\">",
"     \"AIDS-related lymphomas: Clinical manifestations, diagnosis, and staging of systemic lymphoma\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with HIV infection are also at increased risk of developing multicentric Castleman's disease, a Human Herpesvirus 8-associated (HHV-8) condition commonly presenting with anemia, fever and lymphadenopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/51/6970?source=see_link&amp;anchor=H10#H10\">",
"     \"Castleman's disease\", section on 'Multicentric Castleman's disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Nutritional deficiencies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nutritional deficiencies are common in patients with advanced immunosuppression, stemming from the combined impact of anorexia, medication-associated gastrointestinal disturbances, wasting, and malabsorption. As an example, reduced serum vitamin B12 concentrations have been noted in more than 10 percent of outpatients with HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/16\">",
"     16",
"    </a>",
"    ] and as many as 20 percent of patients with AIDS [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The etiology of vitamin B12 deficiency in these patients has been linked to malabsorption in the distal ileum [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/18\">",
"     18",
"    </a>",
"    ], achlorhydria with a secondary reduction in intrinsic factor production, and an alteration in cobalamin transport proteins [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/17\">",
"     17",
"    </a>",
"    ]. In HIV-infected individuals, vitamin B12 deficiency is uncommonly associated with megaloblastic changes in the bone marrow or the neurologic sequelae characteristically encountered in the non-HIV population. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/32/11786?source=see_link\">",
"     \"Etiology and clinical manifestations of vitamin B12 and folate deficiency\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23782?source=see_link\">",
"     \"Physiology of vitamin B12 and folate deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Folate deficiency can occur in HIV-infected patients and may result from reductions in both dietary intake and intestinal absorption [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/19\">",
"     19",
"    </a>",
"    ]. Folate deficiency should be considered in patients at high risk for reduced dietary intake and those with an elevated mean corpuscular volume or megaloblastic changes on blood smear (",
"    <a class=\"graphic graphic_picture graphicRef58820 \" href=\"UTD.htm?4/47/4854\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Hypogonadism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypogonadism is frequently reported among patients with advanced HIV infection. In one cross-sectional observational assessment of 200 HIV-infected patients, anemia (ie, hemoglobin &lt;13.5",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    in men and &lt;11.6",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    in women) was associated with low testosterone levels (adjusted OR 3.23, 95% CI 1.01-10.6) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/20\">",
"     20",
"    </a>",
"    ]. In addition, the presence of anemia was negatively correlated with the usage of androgen medications (adjusted OR 0.20, 95% CI 0.05-0.84).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Abnormal iron metabolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Iron studies are typically consistent with the anemia of inflammation (anemia of chronic disease), characterized by reduced concentrations of serum iron and total iron binding capacity and a normal or increased concentration of serum ferritin [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9434?source=see_link\">",
"     \"Anemia of chronic disease (anemia of chronic inflammation)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In some cases, however, there is evidence of iron deficiency anemia, typically related to gastrointestinal blood loss. Potential causes include intestinal Kaposi's sarcoma, gastrointestinal ulceration, gastritis, and intestinal infections with various viral (especially CMV), bacterial, and parasitic agents. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26234?source=see_link\">",
"     \"Causes and diagnosis of anemia due to iron deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Hemolysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemolysis may play a role in HIV-associated anemia. A variety of mechanisms may be involved, including antibody-mediated hemolysis, drug-induced disease in patients with glucose-6- phosphate dehydrogenase (G6PD) deficiency, and microangiopathic hemolytic anemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Antibody-mediated",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of antibodies directed against red cell antigens is more common than overt hemolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/22\">",
"     22",
"    </a>",
"    ]. In one study, a positive direct antiglobulin test (Coombs' test) was encountered in 18 percent of patients with AIDS, compared with less than 1 percent of non-infected blood donors [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/23\">",
"     23",
"    </a>",
"    ]. Despite this finding, clinically evident hemolysis was not noted in any of the 55 HIV-infected patients.",
"   </p>",
"   <p>",
"    The most common antibodies are directed against U and i antigens on the red blood cell surface. In one series of 28 hospitalized patients with AIDS, 43 percent had a positive direct Coombs' test, and 64 and 32 percent tested positive for anti-i and anti-U, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/24\">",
"     24",
"    </a>",
"    ]. This laboratory anomaly has been ascribed to the generalized hypergammaglobulinemia seen in HIV infection, although it is possible that anti-i reactivity resulted from active EBV or CMV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/23,24\">",
"     23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although uncommon, typical warm antibody autoimmune hemolytic anemia has been described in patients with HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/25\">",
"     25",
"    </a>",
"    ]. The relative reticulocytopenia, frequently seen in these patients because of bone marrow suppression, may lead physicians to underdiagnose this complication.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Drug-induced",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of drugs can be associated with hemolysis in patients with HIV infection.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/59/32688?source=see_link\">",
"       Dapsone",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/59/38837?source=see_link\">",
"       primaquine",
"      </a>",
"      therapy may cause mild reductions in hemoglobin values. Severe, life-threatening hemolysis occurs in HIV-infected patients with G6PD deficiency who are exposed to these or other medications with oxidant potential.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/25/27033?source=see_link\">",
"       Ribavirin",
"      </a>",
"      therapy is commonly associated with the development of hemolytic anemia [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/26\">",
"       26",
"      </a>",
"      ]. Thus, patients co-infected with HIV and hepatitis C who receive combination therapy with alfa-interferon and ribavirin should be carefully monitored for the development of clinically significant anemia [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/27\">",
"       27",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/9/16538?source=see_link&amp;anchor=H2#H2\">",
"       \"Management of the side effects of peginterferon and ribavirin being used for treatment of chronic hepatitis C virus infection\", section on 'Hematologic side effects'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In one retrospective study of HIV-HCV co-infected patients treated with pegylated alfa-interferon and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/25/27033?source=see_link\">",
"     ribavirin",
"    </a>",
"    , the most significant predictors of severe hematologic toxicity were concomitant",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/28/24008?source=see_link\">",
"     zidovudine",
"    </a>",
"    therapy, body weight &lt;65 kilograms, cirrhosis, and baseline hemoglobin &lt;14",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/28\">",
"     28",
"    </a>",
"    ]. To reduce the frequency of significant anemia during HCV therapy, consideration should be given to excluding zidovudine from the antiretroviral therapy regimens of all co-infected patients receiving ribavirin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/38/18026?source=see_link&amp;anchor=H819606#H819606\">",
"     \"Treatment of hepatitis C virus infection in the HIV-infected patient\", section on 'Potential drug interactions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Microangiopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Microangiopathic hemolysis is a hallmark of disseminated intravascular coagulation (DIC) secondary to bacterial sepsis and is also seen in thrombotic thrombocytopenic",
"    <span class=\"nowrap\">",
"     purpura/hemolytic",
"    </span>",
"    uremic syndrome",
"    <span class=\"nowrap\">",
"     (TTP/HUS).",
"    </span>",
"    The presence of schistocytes on the peripheral blood smear is a hallmark of these disorders (",
"    <a class=\"graphic graphic_picture graphicRef70851 \" href=\"UTD.htm?37/50/38694\">",
"     picture 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/1/29721?source=see_link\">",
"     \"Diagnosis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/61/36826?source=see_link&amp;anchor=H112794614#H112794614\">",
"     \"Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults\", section on 'HIV infection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Bone marrow suppression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple therapies used in the management of HIV infection and its related conditions can suppress erythropoiesis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Zidovudine (AZT)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone marrow suppression is the most common toxicity observed in patients treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/28/24008?source=see_link\">",
"     zidovudine",
"    </a>",
"    (AZT). In phase I clinical trials evaluating the efficacy of AZT monotherapy, anemia (hemoglobin &lt;7.5",
"    <span class=\"nowrap\">",
"     g/dL)",
"    </span>",
"    was observed in almost 25 percent of patients treated with 1.5",
"    <span class=\"nowrap\">",
"     g/day",
"    </span>",
"    of AZT; 21 percent of treated patients required transfusions [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/29\">",
"     29",
"    </a>",
"    ]. Subsequent experience has demonstrated a reduced frequency of anemia with lower daily doses of AZT. Patients with advanced immunosuppression are more prone to inhibition of normal erythropoiesis by AZT.",
"   </p>",
"   <p>",
"    Macrocytosis (ie, increased mean corpuscular volume, MCV) is more common than anemia in patients treated with AZT. Within one to two weeks after the institution of AZT therapy, most patients develop a significantly elevated mean corpuscular volume (MCV), secondary to inhibition of nucleic acid synthesis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21767?source=see_link&amp;anchor=H6#H6\">",
"     \"Macrocytosis\", section on 'Interference with DNA synthesis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This phenomenon is so common that AZT treatment was the most frequent cause of macrocytosis (MCV &gt;110 fL) in 100 consecutive inpatients in a large metropolitan hospital, accounting for 44 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/30\">",
"     30",
"    </a>",
"    ]. Less pronounced macrocytosis has also been described among patients receiving",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/45/43734?source=see_link\">",
"     stavudine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/31,32\">",
"     31,32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Other agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other currently approved antiretroviral therapies are rarely associated with bone marrow suppression of this frequency or magnitude. However, bone marrow suppression can be induced by many other drugs used for the prophylaxis or therapy of opportunistic processes, including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/30/33248?source=see_link\">",
"     ganciclovir",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/37/5718?source=see_link\">",
"     valganciclovir",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/16/16648?source=see_link\">",
"     hydroxyurea",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     Amphotericin B",
"    </a>",
"    , and TMP-SMX (",
"    <a class=\"graphic graphic_table graphicRef70219 \" href=\"UTD.htm?22/3/22587\">",
"     table 2",
"    </a>",
"    ). Thus, specific attention to a patient's current medications is a necessity in the assessment of anemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Possible role of HIV",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV itself appears to be a major contributor to abnormalities in hematopoiesis. Retroviral infection has been clearly demonstrated in CD4+ lymphocytes, macrophages, monocytes, and follicular dendritic cells [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/33\">",
"     33",
"    </a>",
"    ]. In comparison, infection of CD34+ bone marrow progenitor cells remains controversial.",
"   </p>",
"   <p>",
"    The in vitro ability of HIV to infect CD34+ cells from healthy donors has been suggested by finding viral inclusions on electron microscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/34\">",
"     34",
"    </a>",
"    ] and demonstrated by nucleic acid amplification [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/35\">",
"     35",
"    </a>",
"    ]. However, most investigators have been unable to detect [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/36\">",
"     36",
"    </a>",
"    ] or have detected only small amounts of HIV-derived DNA [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/37\">",
"     37",
"    </a>",
"    ] from CD34+ progenitor cells isolated from HIV-positive patients. Furthermore, the most primitive subset of CD34+ cells appears to be highly resistant to HIV infection, despite HIV receptor expression [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some of these differences may be explained by observations that the ability of the HIV-1 subtype C to infect hematopoietic progenitor cells is greater than that of HIV-1 subtype B [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/39\">",
"     39",
"    </a>",
"    ]. This hematotropism was found to be associated with higher rates of anemia in southern Africa, where infection with HIV-1 subtype C is more common.",
"   </p>",
"   <p>",
"    Further evidence of HIV-induced impairment in normal erythropoiesis was provided by a comparative analysis of purified CD34+ progenitor cells from 12 HIV-infected patients and 31 uninfected controls. Investigators identified increased levels of erythroid burst-forming units (BFU-E) in untreated HIV-infected patients compared to controls. BFU-Es decreased significantly, however, in these patients following the initiation of antiretroviral therapy. Antiretroviral therapy was also associated with increases in serum erythropoietin levels and soluble transferrin receptors [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     ROLE OF BONE MARROW EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone marrow aspiration and biopsy is often performed during the evaluation of anemia and other cytopenias in patients with HIV infection. A broad spectrum of biopsy findings can be seen, but no histologic abnormality can be considered pathognomonic.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Normocellular marrows are the most common, occurring in over 70 percent of patients in one series [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/41\">",
"       41",
"      </a>",
"      ]. Hypercellularity and, less often, hypocellularity were seen in the remaining patients.",
"     </li>",
"     <li>",
"      Increased plasma cells, histiocytes and marrow reticular cells have been noted in many series [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/42\">",
"       42",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Frank megaloblastic changes may be noted in patients receiving AZT or those with severe B12 or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/61/9174?source=see_link\">",
"       folic acid",
"      </a>",
"      deficiencies.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As an example, a detailed morphologic review was performed in a blinded fashion on 216 bone marrow specimens from 178 patients with HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/43\">",
"     43",
"    </a>",
"    ]. Among the most common bone marrow findings were hypercellularity (53 percent of specimens), myelodysplasia (69 percent), evidence of reticuloendothelial iron blockade (ie, anemia of chronic inflammation, 65 percent), megaloblastic hematopoiesis (38 percent), fibrosis (20 percent), plasmacytosis (25 percent), lymphocytic aggregates (36 percent), and granulomas (13 percent). In 7 of 14 patients found to have marrow involvement by malignant cells, the bone marrow represented the initial site of diagnosis.",
"   </p>",
"   <p>",
"    Bone marrow aspirates and biopsies may reveal the etiology of anemia by demonstrating infiltrative malignancies, infiltrative infections caused by mycobacteria or fungi, or the characteristic giant pronormoblasts encountered in parvovirus B19 disease (",
"    <a class=\"graphic graphic_picture graphicRef51435 \" href=\"UTD.htm?26/42/27304\">",
"     picture 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In a report of 130 bone marrow assessments performed at a London HIV treatment center, bone marrow aspirations provided meaningful diagnostic information in 30 percent of patients presenting with concomitant cytopenia and fever in the absence of other localizing signs. Mycobacterial infections, lymphoma, and Castleman's disease were identified in 15, 6, and 3 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite these observations, existing data do not support the use of bone marrow sampling as a routine diagnostic test in HIV-infected patients with anemia. This was illustrated in a study that compared the utility of bone marrow biopsy and culture to lysis centrifuge blood cultures for the diagnosis of mycobacterial infections [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/45\">",
"     45",
"    </a>",
"    ]. There was no difference in the time required to obtain positive cultures from blood or bone marrow, and culture results from both sites were concordant in 84 percent of the 76 patients evaluated. In patients with clinically diagnosed mycobacterial infections (MAC or M. tuberculosis), only 6 of 21 (29 percent) had histologically detectable acid-fast bacilli in the bone marrow.",
"   </p>",
"   <p>",
"    The one advantage of marrow sampling is the rapidity with which a histologic diagnosis may be made. Thus, in patients with a rapidly changing clinical picture, the speed of processing justifies marrow sampling. Bone marrow biopsies are also performed in the setting of cytopenia with unexplained constitutional symptoms (fever, weight loss, anorexia), when atypical cells are noted in the peripheral blood, or as staging for a diagnosed lymphoma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of anemia in HIV-infected patients should begin with treatment of the HIV infection as well as correction of all of the reversible causes of anemia present in that particular patient. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Etiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Effect of HAART",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of studies have shown that initiation of HAART reduces both the incidence and degree of anemia in all groups of HIV-infected patients (ie, men, women, injection drug users) [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/3,46-50\">",
"     3,46-50",
"    </a>",
"    ]. The following observations from two of the largest series illustrate the range of findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Women's Interagency HIV study (WIHS) evaluated 2056 HIV-1 infected women between October 1994 and September 1998 for the development of anemia (Hgb &lt;12",
"      <span class=\"nowrap\">",
"       g/dL)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/3\">",
"       3",
"      </a>",
"      ]. The prevalence of anemia was 37 and 47 percent at baseline and at 3.5 years, respectively. On multivariate analysis, only the use of HAART for two or more six-month intervals was associated with a significantly reduced risk for the subsequent development of anemia (odds ratio (OR) 0.71, 95% CI 0.57-0.88).",
"     </li>",
"     <li>",
"      In a longitudinal Seattle study including 2493 HIV-infected persons, the incidence of anemia in those treated with HAART was significantly reduced from 23 percent in the pre-HAART period to 4 percent after the introduction of HAART [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These two reports also identified patients with a significantly increased risk of developing anemia despite treatment with HAART:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the WIHS study, HIV-infected women were significantly less likely to have resolution of their anemia during the follow-up period if they had any of four factors associated with an increased risk of developing anemia at baseline: mean corpuscular volume (MCV) &lt;80 fL, CD4 count",
"      <span class=\"nowrap\">",
"       &lt;200/microL,",
"      </span>",
"      HIV-1 viral load",
"      <span class=\"nowrap\">",
"       &gt;50,000/mL,",
"      </span>",
"      or use of AZT in the past six months [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the Seattle study, the incidence of anemia did not change in patients with a CD4 count",
"      <span class=\"nowrap\">",
"       &lt;100/microL",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Correcting reversible causes of anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to primary treatment of the underlying HIV infection, therapy of the anemia should also focus on correcting potentially reversible causes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infectious etiologies warrant aggressive treatment.",
"     </li>",
"     <li>",
"      Uncommon hematologic complications, such as warm autoimmune hemolytic anemia and thrombotic thrombocytopenic purpura appear to respond to standard treatments for these diseases. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/62/14313?source=see_link\">",
"       \"Treatment of autoimmune hemolytic anemia: Warm agglutinins\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/31/42490?source=see_link\">",
"       \"Treatment and prognosis of thrombotic thrombocytopenic purpura-hemolytic uremic syndromes in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Intravenous immune globulin is the therapy of choice for patients with pure red cell aplasia and documented parvovirus B19 infection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/1/31767?source=see_link\">",
"       \"Treatment and prevention of parvovirus B19 infection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Treatment with therapeutic doses of vitamin B12, folate,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      iron is indicated when one or more of these deficiencies is detected.",
"     </li>",
"     <li>",
"      When clinically feasible, attempts at dose reduction or discontinuation of implicated medications should be considered. When discontinuation of medications is not possible, or when secondary causes are not identified, alternative strategies for augmenting red blood cell reserves are indicated (eg, transfusion, use of erythropoietic stimulating agents).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Transfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transfusion remains the mainstay of therapy for acute, life-endangering blood loss or severely symptomatic anemia of any cause. While the administration of packed red blood cells offers rapid correction of anemia and reversal of symptoms, there are several inherent risks, such as transfusion reactions, transmissible infection (eg, viral hepatitis, HTLV-I, CMV), development of alloantibodies and, when repeated transfusion is required, iron overload and its associated complications. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/41/40601?source=see_link&amp;anchor=H8#H8\">",
"     \"Laboratory testing of donated blood\", section on 'Infectious disease screening'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/60/38856?source=see_link&amp;anchor=H11#H11\">",
"     \"Iron overload syndromes other than hereditary hemochromatosis\", section on 'Transfusional iron overload'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     CMV status",
"    </span>",
"    &nbsp;&mdash;&nbsp;To minimize the risk of CMV transmission to CMV-seronegative recipients, most experts advocate the use of CMV-seronegative blood. When CMV-seronegative blood is not available, blood products should be administered through a leukocyte filtering system [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/51\">",
"     51",
"    </a>",
"    ]. However, since the majority of HIV-infected patients have evidence of past CMV infection, this approach is rarely necessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Transfusion-associated graft versus host disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because HIV-infected patients are immunocompromised, the possibility of developing transfusion-associated graft-versus-host disease (ta-GVHD) has been raised for those receiving unmodified red blood cells. One interesting observation for which there is as yet no explanation is that ta-GVHD has not been described in a patient with AIDS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/35/6710?source=see_link\">",
"     \"Transfusion-associated graft-versus-host disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As an example, sustained presence of donor cells or markers (microchimerism) was not found in one study of HIV-infected women receiving leukoreduced versus unmodified red blood cells from male donors [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Viral activation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another concern is the potential risk of enhanced viral activity or impaired immunologic function after the transfusion of blood products. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/5/24665?source=see_link&amp;anchor=H2#H2\">",
"     \"Leukoreduction to prevent complications of blood transfusion\", section on 'Potential adverse effects of transfused leukocytes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It has been suggested that the infusion of blood products may directly activate HIV replication [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/53-55\">",
"     53-55",
"    </a>",
"    ]. Compatible with this hypothesis are the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a prospective comparison of the impact of factor VIII infusions on HIV progression in hemophiliacs, more rapid decrements in CD4 counts were noted in patients who received intermediate-purity versus high-purity factor infusions (in this case, factor VIII purified with monoclonal antibodies) [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another study compared 360 patients who received blood transfusions within the first three months after AIDS diagnosis to untransfused patients with comparable levels of anemia [",
"      <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/55\">",
"       55",
"      </a>",
"      ]. After controlling for the severity of illness, there was a trend toward reduced survival in the patients who had received transfusions.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Unfortunately, potential confounding variables plague these and many other retrospective investigations. As a result, prospective analysis of the potential immunosuppressive effect of blood transfusion in HIV-infected patients is needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Leukoreduction",
"    </span>",
"    &nbsp;&mdash;&nbsp;The VATS (Viral Activation Transfusion Study) randomized, double-blind trial compared viral activity, immune function and survival in a cohort of 531 AIDS patients co-infected with CMV who received leukoreduced or unmodified packed red blood cell transfusions for anemia [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/56\">",
"     56",
"    </a>",
"    ]. No differences in viral load of HIV or CMV, CD4 cell counts, cytokine levels, transfusion reactions, development of opportunistic infections, or death were observed between the two groups. A continuation study showed no significant induction of HBV, HCV, HHV-8, HTLV-I, or HTLV-II viral replication following allogeneic transfusion of non-WBC-reduced blood [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/57,58\">",
"     57,58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While it does not appear that leukoreduction is necessary to avoid inducing other viruses in HIV-infected patients, the issue of leukoreduction to prevent complications in transfusion recipients is controversial and is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/5/24665?source=see_link&amp;anchor=H11#H11\">",
"     \"Leukoreduction to prevent complications of blood transfusion\", section on 'Viral diseases'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/5/24665?source=see_link&amp;anchor=H20#H20\">",
"     \"Leukoreduction to prevent complications of blood transfusion\", section on 'Summary'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Recombinant human erythropoietin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/48/2825?source=see_link\">",
"     Recombinant human erythropoietin",
"    </a>",
"    has been approved by the United States FDA for the treatment of anemia (eg,",
"    <span class=\"nowrap\">",
"     elevate/maintain",
"    </span>",
"    red blood cell level and decrease the need for transfusions) associated with HIV (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/28/24008?source=see_link\">",
"     zidovudine",
"    </a>",
"    ) therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/59\">",
"     59",
"    </a>",
"    ], although no studies have evaluated the effect of EPO on overall survival of these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An overview of four prospective, randomized, double-blind, placebo-controlled clinical trials summarized the impact of rEPO on the management of HIV-associated anemia. Patients with a clinical diagnosis of AIDS under treatment with AZT and with baseline hematocrits &lt;30 percent were randomly assigned to receive 100 to 200",
"    <span class=\"nowrap\">",
"     U/kg",
"    </span>",
"    of rEPO (subcutaneously or intravenously) or placebo three times per week for 12 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/61\">",
"     61",
"    </a>",
"    ]. Baseline serum erythropoietin levels ranged from 10 to 4000 international",
"    <span class=\"nowrap\">",
"     units/L.",
"    </span>",
"    Endpoints included an elevation in hematocrit to greater than 38 percent without the need for transfusion over 4 to 12 weeks of therapy.",
"   </p>",
"   <p>",
"    Among 255 patients with baseline serum erythropoietin concentrations &le;500 international",
"    <span class=\"nowrap\">",
"     units/L,",
"    </span>",
"    69 percent had significant increases in hematocrit and reduced transfusion requirements following treatment with rEPO. Despite these benefits, more than 50 percent of the patients still required transfusion at some point during the trial. No beneficial effect on transfusion requirement was found in patients with baseline serum erythropoietin values &gt;500 international",
"    <span class=\"nowrap\">",
"     units/L.",
"    </span>",
"   </p>",
"   <p>",
"    A subsequent large prospective study involved over 1900 HIV-infected anemic patients with serum EPO levels &le;500 international",
"    <span class=\"nowrap\">",
"     units/L,",
"    </span>",
"    in whom hemolysis, bleeding and deficiencies of B12, folate or iron were excluded [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/62\">",
"     62",
"    </a>",
"    ]. Mean hematocrits increased from 28 to 33 percent after 24 weeks of rEPO (4000 to 8000 U subcutaneously six times per week) and the rate of transfusion fell significantly from 40 percent in the six weeks before the study to 29, 22, and 13 percent after 6, 12, and 48 weeks, respectively. rEPO was particularly effective in the subgroup of patients who were receiving AZT throughout the majority of the trial.",
"   </p>",
"   <p>",
"    Based upon clinical studies, therapy with rEPO, or darbepoetin which can be given less often than rEPO with the same efficacy, should be reserved for patients with symptomatic anemia in whom serum erythropoietin concentrations are &lt;500 international",
"    <span class=\"nowrap\">",
"     units/L.",
"    </span>",
"    Iron reserves should be monitored throughout therapy and replenished as necessary. An initial rEPO dose of 100",
"    <span class=\"nowrap\">",
"     U/kg",
"    </span>",
"    subcutaneously three times weekly is usually recommended, with an increase of more than 5 percentage points or an elevation to more than 30 to 33 percent as the targeted goal. In most cases, increases in hematocrit are evident after two weeks. Dose escalation by 50",
"    <span class=\"nowrap\">",
"     U/kg",
"    </span>",
"    should be considered if no response has been noted after four to eight weeks of therapy; further increases are recommended every four to eight weeks until reaching the targeted hematocrit or the maximal rEPO dose (300",
"    <span class=\"nowrap\">",
"     U/kg).",
"    </span>",
"   </p>",
"   <p>",
"    Many clinicians have chosen to employ a simplified weekly regimen of rEPO for patients with HIV-associated anemia [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/63\">",
"     63",
"    </a>",
"    ]. Specifically, 40,000 units of rEPO are administered subcutaneously on a once-weekly schedule [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/64\">",
"     64",
"    </a>",
"    ]. In one randomized study of 285 HIV-infected adults with Hgb levels &lt;12",
"    <span class=\"nowrap\">",
"     g/dL,",
"    </span>",
"    the use of this weekly regimen was compared with the more traditional dosage of 100 to 300",
"    <span class=\"nowrap\">",
"     units/kg",
"    </span>",
"    three times weekly [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/65\">",
"     65",
"    </a>",
"    ]. Following 16 weeks of therapy, there were no significant differences between the two dosing groups in terms of hemoglobin responses, tolerability, and improvements in quality of life. Improvements in hemoglobin are usually noted after two to four weeks of once-weekly therapy.",
"   </p>",
"   <p>",
"    Among a group of 650 HIV-positive patients with baseline hemoglobins &le;11",
"    <span class=\"nowrap\">",
"     g/dL,",
"    </span>",
"    the use of rEPO at a starting dose of 40,000 units SQ once each week (increased to 60,000 units weekly if the Hgb increase was &lt;1",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    after four weeks) was associated with a significant mean Hgb increase of 2.5",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (95% CI: 2.3-2.6",
"    <span class=\"nowrap\">",
"     g/dL)",
"    </span>",
"    following eight weeks of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/63\">",
"     63",
"    </a>",
"    ]. The once-weekly dosing regimen of rEPO was associated with significant increases in reported quality of life and energy level as measured by the Linear Analog Scale Assessment (LASA) score.",
"   </p>",
"   <p>",
"    Recombinant erythropoietin is generally well tolerated. The most common side effects encountered in the largest clinical trial included nausea, headache, hypertension, seizure, and rash or local reactions at the injection site [",
"    <a class=\"abstract\" href=\"UTD.htm?3/1/3098/abstract/62\">",
"     62",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/31/5626?source=see_link&amp;anchor=H15#H15\">",
"     \"Erythropoietin for the anemia of chronic kidney disease in hemodialysis patients\", section on 'Side effects'",
"    </a>",
"    .) rEPO represents an attractive alternative to transfusion in patients who can tolerate and manage the self-injection regimen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Significance of anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of anemia in the HIV-infected patient is considerable, even in the HAART era. The etiology of the anemia is most often multifactorial, reflecting the additive effects of infection, malignancy, malnutrition, and polypharmacy (",
"    <a class=\"graphic graphic_table graphicRef65608 \" href=\"UTD.htm?24/50/25388\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef70219 \" href=\"UTD.htm?22/3/22587\">",
"     table 2",
"    </a>",
"    ). The presence of anemia is associated with increased morbidity and mortality in patients with HIV infection and mortality rates fall in those who recover from the anemia. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Etiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Diagnostic approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;The finding of a low hematocrit or hemoglobin concentration in an HIV-infected patient warrants careful hematologic evaluation, including all of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Complete blood count with red cell indices, reticulocytes, and examination of the peripheral blood smear",
"     </li>",
"     <li>",
"      Serum bilirubin, lactate dehydrogenase, haptoglobin levels, and direct antiglobulin (Coombs) testing",
"     </li>",
"     <li>",
"      Vitamin B12 and serum folate levels",
"     </li>",
"     <li>",
"      Serum iron, transferrin, and ferritin levels",
"     </li>",
"     <li>",
"      In cases of refractory or unexplained anemia, serum erythropoietin levels and bone marrow aspiration and biopsy should be obtained.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Opportunistic infections and the presence of malignancy must be carefully excluded. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Infections'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/20/16712?source=see_link\">",
"     \"Screening laboratory tests in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      All reversible causes of anemia should be treated using standard approaches, including opportunistic infections, nutritional deficiencies (eg, iron, folate, B12), drug-induced anemia, autoimmune hemolytic anemia, thrombotic thrombocytopenic purpura, and co-existing malignancies. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Correcting reversible causes of anemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Initiation of HAART reduces both the incidence and degree of anemia in all groups of HIV-infected patients and should be aggressively pursued. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Effect of HAART'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36234?source=see_link\">",
"       \"Selecting antiretroviral regimens for the treatment naive HIV-infected patient\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Bone marrow suppression with resultant macrocytic anemia can be seen with the use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/28/24008?source=see_link\">",
"       zidovudine",
"      </a>",
"      (ZDV, AZT) in HIV treatment regimens. This can be managed with discontinuation of the agent or with the use of an erythropoiesis-stimulating agent (eg, erythropoietin, darbepoetin).",
"     </li>",
"     <li>",
"      For HIV-infected patients who remain anemic despite the above treatment approaches, and especially for those whose iron studies are consistent with the anemia of (chronic) inflammation, we recommend institution of therapy with an erythropoiesis-stimulating agent at standard doses, rather than no additional treatment (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H30\">",
"       'Recombinant human erythropoietin'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9434?source=see_link&amp;anchor=H9#H9\">",
"       \"Anemia of chronic disease (anemia of chronic inflammation)\", section on 'Iron studies'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients most likely to respond to this treatment have serum erythropoietin levels &lt;500 international",
"    <span class=\"nowrap\">",
"     units/L.",
"    </span>",
"   </p>",
"   <p>",
"    Transfusion of packed red blood cells may still be required for symptomatic relief of anemia. If given, the red cell products should be leukoreduced and irradiated. To minimize the risk of CMV transmission to CMV-seronegative recipients, most experts advocate the use of CMV-seronegative blood.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/1\">",
"      Zon LI, Arkin C, Groopman JE. Haematologic manifestations of the human immune deficiency virus (HIV). Br J Haematol 1987; 66:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/2\">",
"      Sullivan PS, Hanson DL, Chu SY, et al. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 1998; 91:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/3\">",
"      Berhane K, Karim R, Cohen MH, et al. Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study. J Acquir Immune Defic Syndr 2004; 37:1245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/4\">",
"      Wenger JD, Whalen CC, Lederman MM, et al. Prognostic factors in acquired immunodeficiency syndrome. J Gen Intern Med 1988; 3:464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/5\">",
"      Sathe SS, Gascon P, Lo W, et al. Severe anemia is an important negative predictor for survival with disseminated Mycobacterium avium-intracellulare in acquired immunodeficiency syndrome. Am Rev Respir Dis 1990; 142:1306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/6\">",
"      Moore RD. Anemia and human immunodeficiency virus disease in the era of highly active antiretroviral therapy. Semin Hematol 2000; 37:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/7\">",
"      O'Brien ME, Kupka R, Msamanga GI, et al. Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J Acquir Immune Defic Syndr 2005; 40:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/8\">",
"      Cross Continents Collaboration for Kids (3Cs4kids) Analysis and Writing Committee. Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis. AIDS 2008; 22:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/9\">",
"      Semba RD, Shah N, Klein RS, et al. Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin Infect Dis 2002; 34:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/10\">",
"      Mocroft A, Kirk O, Barton SE, et al. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. AIDS 1999; 13:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/11\">",
"      Mootsikapun P, Srikulbutr S. Histoplasmosis and penicilliosis: comparison of clinical features, laboratory findings and outcome. Int J Infect Dis 2006; 10:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/12\">",
"      van Elsacker-Neile AM, Kroon FP, van der Ende ME, et al. Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus. Clin Infect Dis 1996; 23:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/13\">",
"      Chernak E, Dubin G, Henry D, et al. Infection due to parvovirus B19 in patients infected with human immunodeficiency virus. Clin Infect Dis 1995; 20:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/14\">",
"      Abkowitz JL, Brown KE, Wood RW, et al. Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection. J Infect Dis 1997; 176:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/15\">",
"      Stebbing J, Pantanowitz L, Dayyani F, et al. HIV-associated multicentric Castleman's disease. Am J Hematol 2008; 83:498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/16\">",
"      Hepburn MJ, Dyal K, Runser LA, et al. Low serum vitamin B12 levels in an outpatient HIV-infected population. Int J STD AIDS 2004; 15:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/17\">",
"      Burkes RL, Cohen H, Krailo M, et al. Low serum cobalamin levels occur frequently in the acquired immune deficiency syndrome and related disorders. Eur J Haematol 1987; 38:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/18\">",
"      Harriman GR, Smith PD, Horne MK, et al. Vitamin B12 malabsorption in patients with acquired immunodeficiency syndrome. Arch Intern Med 1989; 149:2039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/19\">",
"      Revell P, O'Doherty MJ, Tang A, Savidge GF. Folic acid absorption in patients infected with the human immunodeficiency virus. J Intern Med 1991; 230:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/20\">",
"      Behler C, Shade S, Gregory K, et al. Anemia and HIV in the antiretroviral era: potential significance of testosterone. AIDS Res Hum Retroviruses 2005; 21:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/21\">",
"      Sproat LO, Pantanowitz L, Lu CM, Dezube BJ. Human immunodeficiency virus-associated hemophagocytosis with iron-deficiency anemia and massive splenomegaly. Clin Infect Dis 2003; 37:e170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/22\">",
"      Lai M, Visconti E, D'Onofrio G, et al. Lower hemoglobin levels in human immunodeficiency virus-infected patients with a positive direct antiglobulin test (DAT): relationship with DAT strength and clinical stages. Transfusion 2006; 46:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/23\">",
"      Toy PT, Reid ME, Burns M. Positive direct antiglobulin test associated with hyperglobulinemia in acquired immunodeficiency syndrome (AIDS). Am J Hematol 1985; 19:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/24\">",
"      McGinniss MH, Macher AM, Rook AH, Alter HJ. Red cell autoantibodies in patients with acquired immune deficiency syndrome. Transfusion 1986; 26:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/25\">",
"      Telen MJ, Roberts KB, Bartlett JA. HIV-associated autoimmune hemolytic anemia: report of a case and review of the literature. J Acquir Immune Defic Syndr 1990; 3:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/26\">",
"      Virtue MA, Furne JK, Ho SB, Levitt MD. Use of alveolar carbon monoxide to measure the effect of ribavirin on red blood cell survival. Am J Hematol 2004; 76:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/27\">",
"      Zylberberg H, Benhamou Y, Lagneaux JL, et al. Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report. Gut 2000; 47:694.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/28\">",
"      Mira JA, L&oacute;pez-Cort&eacute;s LF, Merino D, et al. Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients. Antivir Ther 2007; 12:1225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/29\">",
"      Richman DD, Fischl MA, Grieco MH, et al. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med 1987; 317:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/30\">",
"      Snower DP, Weil SC. Changing etiology of macrocytosis. Zidovudine as a frequent causative factor. Am J Clin Pathol 1993; 99:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/31\">",
"      Eyer-Silva WA, Arabe J, Pinto JF, Morais-De-S&aacute; CA. Macrocytosis in patients on stavudine. Scand J Infect Dis 2001; 33:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/32\">",
"      Duong M, Piroth L, Peytavin G, et al. Value of patient self-report and plasma human immunodeficiency virus protease inhibitor level as markers of adherence to antiretroviral therapy: relationship to virologic response. Clin Infect Dis 2001; 33:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/33\">",
"      Scadden DT, Zon LI, Groopman JE. Pathophysiology and management of HIV-associated hematologic disorders. Blood 1989; 74:1455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/34\">",
"      Folks TM, Kessler SW, Orenstein JM, et al. Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow. Science 1988; 242:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/35\">",
"      Chelucci C, Hassan HJ, Locardi C, et al. In vitro human immunodeficiency virus-1 infection of purified hematopoietic progenitors in single-cell culture. Blood 1995; 85:1181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/36\">",
"      Molina JM, Scadden DT, Sakaguchi M, et al. Lack of evidence for infection of or effect on growth of hematopoietic progenitor cells after in vivo or in vitro exposure to human immunodeficiency virus. Blood 1990; 76:2476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/37\">",
"      Neal TF, Holland HK, Baum CM, et al. CD34+ progenitor cells from asymptomatic patients are not a major reservoir for human immunodeficiency virus-1. Blood 1995; 86:1749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/38\">",
"      Shen H, Cheng T, Preffer FI, et al. Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression. J Virol 1999; 73:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/39\">",
"      Redd AD, Avalos A, Essex M. Infection of hematopoietic progenitor cells by HIV-1 subtype C, and its association with anemia in southern Africa. Blood 2007; 110:3143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/40\">",
"      Costantini A, Giuliodoro S, Butini L, et al. Abnormalities of erythropoiesis during HIV-1 disease: a longitudinal analysis. J Acquir Immune Defic Syndr 2009; 52:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/41\">",
"      Castella A, Croxson TS, Mildvan D, et al. The bone marrow in AIDS. A histologic, hematologic, and microbiologic study. Am J Clin Pathol 1985; 84:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/42\">",
"      Spivak JL, Bender BS, Quinn TC. Hematologic abnormalities in the acquired immune deficiency syndrome. Am J Med 1984; 77:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/43\">",
"      Karcher DS, Frost AR. The bone marrow in human immunodeficiency virus (HIV)-related disease. Morphology and clinical correlation. Am J Clin Pathol 1991; 95:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/44\">",
"      Llewelyn MJ, Noursedeghi M, Dogan A, et al. Diagnostic utility of bone marrow sampling in HIV-infected patients since the advent of highly active antiretroviral therapy. Int J STD AIDS 2005; 16:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/45\">",
"      Kilby JM, Marques MB, Jaye DL, et al. The yield of bone marrow biopsy and culture compared with blood culture in the evaluation of HIV-infected patients for mycobacterial and fungal infections. Am J Med 1998; 104:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/46\">",
"      Buskin SE, Sullivan PS. Anemia and its treatment and outcomes in persons infected with human immunodeficiency virus. Transfusion 2004; 44:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/47\">",
"      Moore RD, Forney D. Anemia in HIV-infected patients receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 29:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/48\">",
"      Semba RD, Shah N, Vlahov D. Improvement of anemia among HIV-infected injection drug users receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2001; 26:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/49\">",
"      Semba RD, Shah N, Klein RS, et al. Highly active antiretroviral therapy associated with improved anemia among HIV-infected women. AIDS Patient Care STDS 2001; 15:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/50\">",
"      Sullivan PS, Hanson DL, Brooks JT. Impact on hemoglobin of starting combination antiretroviral therapy with or without zidovudine in anemic HIV-infected patients. J Acquir Immune Defic Syndr 2008; 48:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/51\">",
"      van Prooijen HC, Visser JJ, van Oostendorp WR, et al. Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high-affinity filters. Br J Haematol 1994; 87:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/52\">",
"      Kruskall MS, Lee TH, Assmann SF, et al. Survival of transfused donor white blood cells in HIV-infected recipients. Blood 2001; 98:272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/53\">",
"      Mudido PM, Georges D, Dorazio D, et al. Human immunodeficiency virus type 1 activation after blood transfusion. Transfusion 1996; 36:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/54\">",
"      Seremetis SV, Aledort LM, Bergman GE, et al. Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status. Lancet 1993; 342:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/55\">",
"      Vamvakas E, Kaplan HS. Early transfusion and length of survival in acquired immune deficiency syndrome: experience with a population receiving medical care at a public hospital. Transfusion 1993; 33:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/56\">",
"      Collier AC, Kalish LA, Busch MP, et al. Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial. JAMA 2001; 285:1592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/57\">",
"      Asmuth DM, Kalish LA, Laycock ME, et al. Absence of HBV and HCV, HTLV-I and -II, and human herpes virus-8 activation after allogeneic RBC transfusion in patients with advanced HIV-1 infection. Transfusion 2003; 43:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/58\">",
"      Drew WL, Chou S, Mohr BA, et al. Absence of activation of CMV by blood transfusion to HIV-infected, CMV-seropositive patients. Transfusion 2003; 43:1351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/59\">",
"      Henry DH, Volberding PA, Leitz G. Epoetin alfa for treatment of anemia in HIV-infected patients: past, present, and future. J Acquir Immune Defic Syndr 2004; 37:1221.",
"     </a>",
"    </li>",
"    <li>",
"     Marti-Carvajal AJ, Sola I. Treatment for anemia in people with AIDS. Cochrane Database Syst Rev 2007; CD004776.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/61\">",
"      Henry DH, Beall GN, Benson CA, et al. Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials. Ann Intern Med 1992; 117:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/62\">",
"      Phair JP, Abels RI, McNeill MV, Sullivan DJ. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results. Arch Intern Med 1993; 153:2669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/63\">",
"      Saag MS, Bowers P, Leitz GJ, et al. Once-weekly epoetin alfa improves quality of life and increases hemoglobin in anemic HIV+ patients. AIDS Res Hum Retroviruses 2004; 20:1037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/64\">",
"      Volberding P. Consensus statement: anemia in HIV infection--current trends, treatment options, and practice strategies. Anemia in HIV Working Group. Clin Ther 2000; 22:1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?3/1/3098/abstract/65\">",
"      Grossman HA, Goon B, Bowers P, et al. Once-weekly epoetin alfa dosing is as effective as three times-weekly dosing in increasing hemoglobin levels and is associated with improved quality of life in anemic HIV-infected patients. J Acquir Immune Defic Syndr 2003; 34:368.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7083 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-218.7.204.202-34378B5ED4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_1_3098=[""].join("\n");
var outline_f3_1_3098=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H31\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INCIDENCE AND SIGNIFICANCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Effect on mortality",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Infections",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Mycobacteria, fungi, and parasites",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Viral infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Malignancy and lymphoproliferative disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Nutritional deficiencies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Hypogonadism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Abnormal iron metabolism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Hemolysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Antibody-mediated",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Drug-induced",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Microangiopathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Bone marrow suppression",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Zidovudine (AZT)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Other agents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Possible role of HIV",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      ROLE OF BONE MARROW EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Effect of HAART",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Correcting reversible causes of anemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Transfusion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - CMV status",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Transfusion-associated graft versus host disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Viral activation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Leukoreduction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Recombinant human erythropoietin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Significance of anemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Diagnostic approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/7083\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7083|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/47/4854\" title=\"picture 1\">",
"      Megaloblastic smear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/50/38694\" title=\"picture 2\">",
"      Schistocytes on peripheral smear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/42/27304\" title=\"picture 3\">",
"      Giant proerythroblast in PRCA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/7083|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/50/25388\" title=\"table 1\">",
"      Causes of anemia in HIV",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/3/22587\" title=\"table 2\">",
"      Drugs which cause anemia in HIV",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/4/7242?source=related_link\">",
"      AIDS-related lymphomas: Clinical manifestations, diagnosis, and staging of systemic lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/13/9434?source=related_link\">",
"      Anemia of chronic disease (anemia of chronic inflammation)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29418?source=related_link\">",
"      Approach to the adult patient with anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/51/6970?source=related_link\">",
"      Castleman's disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26234?source=related_link\">",
"      Causes and diagnosis of anemia due to iron deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/61/36826?source=related_link\">",
"      Causes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/54/22377?source=related_link\">",
"      Clinical manifestations and pathogenesis of human parvovirus B19 infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/1/29721?source=related_link\">",
"      Diagnosis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/31/5626?source=related_link\">",
"      Erythropoietin for the anemia of chronic kidney disease in hemodialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/32/11786?source=related_link\">",
"      Etiology and clinical manifestations of vitamin B12 and folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/0/44039?source=related_link\">",
"      Hematologic manifestations of HIV infection: Neutropenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/11/14522?source=related_link\">",
"      Hematologic manifestations of HIV infection: Thrombocytopenia and coagulation abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/60/38856?source=related_link\">",
"      Iron overload syndromes other than hereditary hemochromatosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/41/40601?source=related_link\">",
"      Laboratory testing of donated blood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/5/24665?source=related_link\">",
"      Leukoreduction to prevent complications of blood transfusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/16/21767?source=related_link\">",
"      Macrocytosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/9/16538?source=related_link\">",
"      Management of the side effects of peginterferon and ribavirin being used for treatment of chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/14/23782?source=related_link\">",
"      Physiology of vitamin B12 and folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/42/33450?source=related_link\">",
"      Primary prevention of opportunistic infections in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/20/16712?source=related_link\">",
"      Screening laboratory tests in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/24/36234?source=related_link\">",
"      Selecting antiretroviral regimens for the treatment naive HIV-infected patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/52/21320?source=related_link\">",
"      Techniques and interpretation of measurement of the CD4 cell count in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/35/6710?source=related_link\">",
"      Transfusion-associated graft-versus-host disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/1/31767?source=related_link\">",
"      Treatment and prevention of parvovirus B19 infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/31/42490?source=related_link\">",
"      Treatment and prognosis of thrombotic thrombocytopenic purpura-hemolytic uremic syndromes in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/62/14313?source=related_link\">",
"      Treatment of autoimmune hemolytic anemia: Warm agglutinins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/38/18026?source=related_link\">",
"      Treatment of hepatitis C virus infection in the HIV-infected patient",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f3_1_3099="Computed tomography signs of appendicitis";
var content_f3_1_3099=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F58384&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F58384&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Computed tomography signs of acute appendicitis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Wall thickness &gt;2 mm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Appendicolith",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Enlargement of the appendix",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Target sign (concentric thickening of the appendiceal wall)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Phlegmon",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abscess",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Free fluid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thickening of the mesentery, fat stranding (peri-appendiceal inflammation)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_1_3099=[""].join("\n");
var outline_f3_1_3099=null;
var title_f3_1_3100="Three by three grid POP-Q";
var content_f3_1_3100=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F57450&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F57450&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Three-by-three grid used to express the quantified pelvic organ prolapse (POP-Q) system",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 214px; height: 152px; background-image: url(data:image/gif;base64,R0lGODlh1gCYAMQAAP///4CAgEBAQMDAwAAAACAgIKCgoBAQEODg4NDQ0PDw8DAwMGBgYJCQkFBQUHBwcLCwsAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAADWAJgAAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/8nAwNZgoBZAQGHiYZXiIqMjYuRkFaOWJaUU5iVkplRm1Wgnk6imp2jpKdUpahKrJ+qra6xUq+yRrZPubdDu02+vEDAS8PBPcVJyK0PAse0MMwCAgwIO8orAw4EBAsNdgoEBwY81yXTgg4F1s8zEATeABDqdQ0LDA4jBg4CDhA05SQELBpAQIQ+fv5mADxRoJMCO90SEHgIIICBAQYIDJKxUMS5AQLGVbyYcWOMjiQk/1bLg4BAtQIiRSAYsIBdCpQCCkjTSRHAzJoKbcIguCfAAUQLmgEwcOCAgKNBcQgc4YDB0qZPhZ5AOYJgzzsFHCB64LLlxqkcta5AW1GAWY9qS3AdIS6PyhEFGngFoKBh1BtoEzTc2zcuibkijCYQocDqHGaHFwDIKWCB37RStxG4TNmy4RGIRZBNSsAxnwSLa4QugdrGar6CvhqT+xnJ69ksbuvQjftm7SO8e2/9jYu48L+TjhcJfoO58sTGiTh/Pv1f9OcuqiPHLuy6EO1fBiAaT768+fPo05uXpr69+/ft2cOfT7+8ySfi6+uHL3+/f/r9/SegfZmAd5J33KlgIP8MC87WYHYIJojCgy1QyIuFK2Aoi4a+SdjdIx76wOGEEYZ4WIkiomhiRSqS02KIIw63oosgzphDjCbgWOCLu/EooY4n2thjjSYikJprLyawEpJDKHCfHQEoxeQN0QgAD1uqeRfAkiYQlUeUOODEwAAQLPDAZFp6p1EKXsahADMM6NUWBPwceaBUi7gz2QNRMiDbCx1lxEAAA8iZWAJtwrGAAxj5FQABhO5jHZ4iQHDAZAfoJc2kNghK6D0iqJSoG0yNMBWYAIwKqHfnMJUIWi1xuSoOawJw1wNWqcoGqmi2JYKuFbKqkwMisVXrnTccayUABwwCrBoBSAaXr6kWtB3/DVj2yhcBds6arEkGFCDPr9bC8dYAjir1bIasnoJWA/NglmxCIhywgEjrpsFUaUChmm+HgLlr7wIHdOutDQ84tUjCFP27BkzrBDHTnwfbgCjFdTAwaGUYX7uKj3ckgIgBHXtsipA3gtycytgBCRrL1MHMKcpTJkdzlkTeLK/NOu/MiSf5DSh0lAINbXR5AR7t35NNBK30fkk/PWDUUs/H9B8uQ9fzzD9v7XMoMh+XNYtef/1x2cjyjHZuYZu9NsBqvw1313Kzm3PdMl7Sdm9jjw1I33vjBjjeduvtIWQ0UinNNLLWnEOVW94BTl0RAzZmNvGGieJHDBAQ0xz1gGoQ/wR9ljw3tgNZawDp05hOIg9sMeV6GhFN5FGmIEnJIKuXh3S7prpXTClen5vrEgAQaxur2zFQRtlDsB6fdg5YZvuGUUgpZezVhdvAVlXaAnCs8AGT0A0dYY11PFrgGMz28L6yzy3zqI9wlxz3I+/Nu5mTL0NgfuGfyWqAFksFTgmIS4xknrIAgrnvfYDRDGcGVrABYkszAqDXHgSCKJz9gIPcC5aQrDc92F3Hb2a4yMqAoELHES5HB4TQC093thnmLW42JJvhckibu+VwcDwM0g6DqLUhEhGIRExVCKFQiCQ68YlQjKIUp0jFKlrxiljMoha3yMUuevGLYAyjGMdIxgQymiEEADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     Aa: point A of the anterior wall; Ba: point B of the anterior wall; C: cervix or cuff; D: posterior fornix; gh: genital hiatus; pb: perineal body; tvl: total vaginal length; Ap: point A of the posterior wall; Bp: point B of the posterior wall.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Harvey, M-A, Versi, E. Urogynecology and pelvic floor dysfunction. In: Kistner's Gynecology and Women's Health, 7th ed, Ryan, KJ, Berkowitz, RS, Barbieri, RL, Dunaif, A (Eds), St. Louis, Mosby 1999. Copyright &copy; 1999 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_1_3100=[""].join("\n");
var outline_f3_1_3100=null;
var title_f3_1_3101="Common casts";
var content_f3_1_3101=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F69141&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F69141&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Common cast types and fractures that they treat",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Cast type",
"      </td>",
"      <td class=\"subtitle1\">",
"       Fracture(s)",
"      </td>",
"      <td class=\"subtitle1\">",
"       Key features",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Short arm cast",
"       </strong>",
"      </td>",
"      <td>",
"       <p>",
"        MC 2 to 5 base fx",
"       </p>",
"       <p>",
"        Nondisplaced triquetrum fx",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Wrist 30 degrees",
"       </p>",
"       <p>",
"        Top of cast 2 cm below antecubital fossa",
"       </p>",
"       <p>",
"        One to two layers of padding",
"       </p>",
"       <p>",
"        Two layers of casting tape",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Short arm cast",
"       </strong>",
"      </td>",
"      <td>",
"       Nondisplaced distal radius fx (Colles')",
"      </td>",
"      <td>",
"       <p>",
"        Wrist neutral",
"       </p>",
"       <p>",
"        Top of cast 2 cm below antecubital fossa",
"       </p>",
"       <p>",
"        One to two layers of padding",
"       </p>",
"       <p>",
"        Two layers of casting tape",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Long arm cast",
"       </strong>",
"      </td>",
"      <td>",
"       Reduced Colles' fx",
"      </td>",
"      <td>",
"       <p>",
"        Wrist slight flexion and ulnar deviation, elbow 90 degrees",
"       </p>",
"       <p>",
"        Top of cast 3 cm below axilla",
"       </p>",
"       <p>",
"        One to two layers of padding",
"       </p>",
"       <p>",
"        Three layers of casting tape",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Short arm cast with thumb spica",
"       </strong>",
"      </td>",
"      <td>",
"       <p>",
"        1st MC base extraarticular fx",
"       </p>",
"       <p>",
"        Suspected scaphoid fx",
"       </p>",
"       <p>",
"        Nondisplaced distal third scaphoid fx",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Wrist 30 degrees",
"       </p>",
"       <p>",
"        Top of cast 2 cm below antecubital fossa",
"       </p>",
"       <p>",
"        One to two layers of padding",
"       </p>",
"       <p>",
"        Two layers of casting tape",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Long arm cast with thumb spica",
"       </strong>",
"      </td>",
"      <td>",
"       Middle or proximal third nondisplaced scaphoid fx",
"      </td>",
"      <td>",
"       <p>",
"        Wrist 30 degrees",
"       </p>",
"       <p>",
"        Top of cast 3 cm below axilla",
"       </p>",
"       <p>",
"        One to two layers of padding",
"       </p>",
"       <p>",
"        Three layers of casting tape",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Short leg walking cast",
"       </strong>",
"      </td>",
"      <td>",
"       <p>",
"        Isolated fibular shaft fx",
"       </p>",
"       <p>",
"        Isolated maleolar fx or distal fibular shaft fx",
"       </p>",
"       <p>",
"        Calcaneus fx of anterior/medial/lateral process",
"       </p>",
"       <p>",
"        Talar dome (type 1 or 2)/head/avulsion fx",
"       </p>",
"       <p>",
"        Nondisplaced MT shaft fx",
"       </p>",
"       <p>",
"        Proximal 5th MT styloid avulsion fx",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Ankle 90 degrees",
"       </p>",
"       <p>",
"        Top of cast 4 cm below popliteal fossa",
"       </p>",
"       <p>",
"        Three to four layers of padding",
"       </p>",
"       <p>",
"        Four layers of casting tape",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Short leg non-weight bearing cast",
"       </strong>",
"      </td>",
"      <td>",
"       <p>",
"        Calcaneus fx of the sustentaculum tali",
"       </p>",
"       <p>",
"        Talar neck/body fx",
"       </p>",
"       <p>",
"        Reduced MT shaft fx",
"       </p>",
"       <p>",
"        Proximal 5th MT metaphyseal-diaphyseal junction or diaphyseal fx",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Ankle 90 degrees",
"       </p>",
"       <p>",
"        Top of cast 4 cm below popliteal fossa",
"       </p>",
"       <p>",
"        Three to four layers of padding",
"       </p>",
"       <p>",
"        Three layers of casting tape",
"       </p>",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     Fx: fracture; MC: metacarpal; MT: metatarsal.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_1_3101=[""].join("\n");
var outline_f3_1_3101=null;
var title_f3_1_3102="Countercurrent mechanism III";
var content_f3_1_3102=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F80628&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F80628&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Countercurrent multiplication and the excretion of a concentrated urine",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 245px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The transport of NaCl from the ascending limb results in the formation of an interstitial osmalal gradient from 285 mosmol/kg in the cortext to 1200 mosmol/kg at the papillary tip. In the presence of ADH, the urine becomes concentrated as it equilibrates with the interstitium in the medullary collecting tubule. The contribution of urea to the concentrating process is discussed in the text and has been omitted from the diagram.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_1_3102=[""].join("\n");
var outline_f3_1_3102=null;
var title_f3_1_3103="PCI related delay and risk of death";
var content_f3_1_3103=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F67897&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F67897&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 611px\">",
"   <div class=\"ttl\">",
"    Superiority of 1&deg; PCI over lysis lost after a DB - DN delay of 114 minutes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 591px; height: 353px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Pinto DS, Kirtane AJ, Nallamothu BK, et al. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation 2006; 114:2019. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f3_1_3103=[""].join("\n");
var outline_f3_1_3103=null;
